☰

Matthew Brandon Baker - Publications

Affiliations: 
2012 University of Florida, Gainesville, Gainesville, FL, United States 
Tree Info Similar researchers PubMed Report error

122/297 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Josephs KA, Zhang YJ, Baker M, Rademakers R, Petrucelli L, Dickson DW. C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation. Acta Neuropathologica Communications. 7: 100. PMID 31266542 DOI: 10.1186/S40478-019-0755-X  0.329
2019 Hirsch-Reinshagen V, Alfaify OA, Hsiung GR, Pottier C, Baker M, Perkerson RB, Rademakers R, Briemberg H, Foti DJ, Mackenzie IR. Clinicopathologic correlations in a family with a mutation presenting as primary progressive aphasia and primary lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 31244341 DOI: 10.1080/21678421.2019.1632347  0.404
2019 Koga S, Eric Ahlskog J, DeTure MA, Baker M, Roemer SF, Konno T, Rademakers R, Ross OA, Dickson DW. Coexistence of Progressive Supranuclear Palsy With Pontocerebellar Atrophy and Myotonic Dystrophy Type 1. Journal of Neuropathology and Experimental Neurology. PMID 31216016 DOI: 10.1093/Jnen/Nlz048  0.325
2019 Pottier C, Ren Y, Perkerson RB, Baker M, Jenkins GD, van Blitterswijk M, DeJesus-Hernandez M, van Rooij JGJ, Murray ME, Christopher E, McDonnell SK, Fogarty Z, Batzler A, Tian S, Vicente CT, et al. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD. Acta Neuropathologica. PMID 30739198 DOI: 10.1007/S00401-019-01962-9  0.332
2018 Pottier C, Zhou X, Perkerson RB, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, et al. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. The Lancet. Neurology. PMID 29724592 DOI: 10.1016/S1474-4422(18)30126-1  0.399
2018 Pottier C, Rampersaud E, Baker M, Wu G, Wuu J, McCauley JL, Zuchner S, Schule R, Bermudez C, Hussain S, Cooley A, Wallace M, Zhang J, Taylor JP, Benatar M, et al. Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case report. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-3. PMID 29558868 DOI: 10.1080/21678421.2018.1452947  0.36
2017 Hirsch-Reinshagen V, Pottier C, Nicholson AM, Baker M, Hsiung GR, Krieger C, Sengdy P, Boylan KB, Dickson DW, Mesulam M, Weintraub S, Bigio E, Zinman L, Keith J, Rogaeva E, et al. Clinical and neuropathological features of ALS/FTD with TIA1 mutations. Acta Neuropathologica Communications. 5: 96. PMID 29216908 DOI: 10.1017/Cjn.2018.48  0.39
2017 Mackenzie IR, Nicholson AM, Sarkar M, Messing J, Purice MD, Pottier C, Annu K, Baker M, Perkerson RB, Kurti A, Matchett BJ, Mittag T, Temirov J, Hsiung GR, Krieger C, et al. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. Neuron. 95: 808-816.e9. PMID 28817800 DOI: 10.1016/J.Neuron.2017.07.025  0.397
2016 Pottier C, Ravenscroft TA, Brown PH, Finch NA, Baker M, Parsons M, Asmann YW, Ren Y, Christopher E, Levitch D, van Blitterswijk M, Cruchaga C, Campion D, Nicolas G, Richard AC, et al. TYROBP genetic variants in early-onset Alzheimer's disease. Neurobiology of Aging. PMID 27658901 DOI: 10.1016/J.Neurobiolaging.2016.07.028  0.357
2016 Baker MB, Ferreira RB, Tasseroul J, Lampkins AJ, Al Abbas A, Abboud KA, Castellano RK. The Selective and Sequential Aminolysis of Benzotrifuranone: A Synergism of Electronic Effects and a Ring Strain Gradient. The Journal of Organic Chemistry. PMID 27580412 DOI: 10.1021/Acs.Joc.6B01867  0.577
2015 Singh N, Joshi S, Guo L, Baker M, Li Y, Castellano R, Raizada MK, Jarajapu YP. ACE2/Ang-(1-7)/Mas Axis Stimulates Vascular-Repair Relevant Functions of CD34+ Cells. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00854.2014. PMID 26386115 DOI: 10.1152/Ajpheart.00854.2014  0.577
2015 Pottier C, Bieniek KF, Finch N, van de Vorst M, Baker M, Perkersen R, Brown P, Ravenscroft T, van Blitterswijk M, Nicholson AM, DeTure M, Knopman DS, Josephs KA, Parisi JE, Petersen RC, et al. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathologica. 130: 77-92. PMID 25943890 DOI: 10.1007/S00401-015-1436-X  0.424
2015 Bou Zerdan R, Cohn P, Puodziukynaite E, Baker MB, Voisin M, Sarun C, Castellano RK. Synthesis, optical properties, and electronic structures of nucleobase-containing π-conjugated oligomers. The Journal of Organic Chemistry. 80: 1828-40. PMID 25581330 DOI: 10.1021/Jo502773G  0.584
2015 Pottier C, Baker M, Dickson DW, Rademakers R. PRKAR1B mutations are a rare cause of FUS negative neuronal intermediate filament inclusion disease. Brain : a Journal of Neurology. 138: e357. PMID 25414037 DOI: 10.1093/Brain/Awu332  0.375
2015 Sundal C, Baker M, Karrenbauer V, Gustavsen M, Bedri S, Glaser A, Myhr KM, Haugarvoll K, Zetterberg H, Harbo H, Kockum I, Hillert J, Wszolek Z, Rademakers R, Andersen O. Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 22: 328-33. PMID 25311247 DOI: 10.1111/Ene.12572  0.337
2015 Kertesz A, Finger E, Murrell J, Chertkow H, Ang LC, Baker M, Ravenscroft T, Rademakers R, Munoz DG. Progressive supranuclear palsy in a family with TDP-43 pathology. Neurocase. 21: 178-84. PMID 24479957 DOI: 10.1080/13554794.2013.878729  0.38
2014 Fujioka S, Boeve BF, Parisi JE, Tacik P, Aoki N, Strongosky AJ, Baker M, Sanchez-Contreras M, Ross OA, Rademakers R, Sossi V, Dickson DW, Stoessl AJ, Wszolek ZK. A familial form of parkinsonism, dementia, and motor neuron disease: a longitudinal study. Parkinsonism & Related Disorders. 20: 1129-34. PMID 25175602 DOI: 10.1016/J.Parkreldis.2014.07.014  0.322
2014 Hallam BJ, Jacova C, Hsiung GY, Wittenberg D, Sengdy P, Bouchard-Kerr P, Slack P, Rademakers R, Baker M, Chow TW, Levine B, Feldman HH, Mackenzie IR. Early neuropsychological characteristics of progranulin mutation carriers. Journal of the International Neuropsychological Society : Jins. 20: 694-703. PMID 24993774 DOI: 10.1017/S1355617714000551  0.359
2014 Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, ... ... Baker M, et al. Frontotemporal dementia and its subtypes: a genome-wide association study. The Lancet. Neurology. 13: 686-99. PMID 24943344 DOI: 10.1016/S1474-4422(14)70065-1  0.344
2014 Siuda J, Lewicka T, Bujak M, Opala G, Golenia A, Slowik A, van Blitterswijk M, Baker M, Ertekin-Taner N, Wszolek ZK, Rademakers R. ALS-FTD complex disorder due to C9ORF72 gene mutation: description of first Polish family. European Neurology. 72: 64-71. PMID 24861139 DOI: 10.1159/000362267  0.345
2014 Shinohara M, Fujioka S, Murray ME, Wojtas A, Baker M, Rovelet-Lecrux A, Rademakers R, Das P, Parisi JE, Graff-Radford NR, Petersen RC, Dickson DW, Bu G. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease. Brain : a Journal of Neurology. 137: 1533-49. PMID 24625695 DOI: 10.1093/Brain/Awu046  0.349
2014 Baker M, Strongosky AJ, Sanchez-Contreras MY, Yang S, Ferguson W, Calne DB, Calne S, Stoessl AJ, Allanson JE, Broderick DF, Hutton ML, Dickson DW, Ross OA, Wszolek ZK, Rademakers R. SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia. Neurogenetics. 15: 23-30. PMID 24135862 DOI: 10.1007/S10048-013-0378-5  0.38
2014 Kouri N, Carlomagno Y, Baker M, Liesinger AM, Caselli RJ, Wszolek ZK, Petrucelli L, Boeve BF, Parisi JE, Josephs KA, Uitti RJ, Ross OA, Graff-Radford NR, DeTure MA, Dickson DW, et al. Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration. Acta Neuropathologica. 127: 271-82. PMID 24121548 DOI: 10.1007/S00401-013-1193-7  0.363
2014 Sitek EJ, Narozanska E, Barczak A, Jasinska-Myga B, Harciarek M, Chodakowska-Zebrowska M, Kubiak M, Wieczorek D, Konieczna S, Rademakers R, Baker M, Berdynski M, Brockhuis B, Barcikowska M, Zekanowski C, et al. Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon? Neurocase. 20: 69-86. PMID 23121543 DOI: 10.1080/13554794.2012.732087  0.361
2014 Graff-Radford J, Jones D, Weigand S, Przybelski S, Whitwell JL, Senjem M, Knopman DS, Graff-Radford NR, Josephs K, Wszolek Z, Vemuri P, Fields JA, Ferman TJ, Lucas J, Lowe VJ, ... ... Baker M, et al. Longitudinal Mri And Neuropsychological Changes In Symptomatic Frontotemporal Lobar Degeneration Subjects With Mutations In Mapt, Pgrn, And C9Orf72 Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.04.284  0.331
2013 Kertesz A, Ang LC, Jesso S, MacKinley J, Baker M, Brown P, Shoesmith C, Rademakers R, Finger EC. Psychosis and hallucinations in frontotemporal dementia with the C9ORF72 mutation: a detailed clinical cohort. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 26: 146-54. PMID 24077574 DOI: 10.1097/Wnn.0000000000000008  0.384
2013 Jacova C, Hsiung GY, Tawankanjanachot I, Dinelle K, McCormick S, Gonzalez M, Lee H, Sengdy P, Bouchard-Kerr P, Baker M, Rademakers R, Sossi V, Stoessl AJ, Feldman HH, Mackenzie IR. Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers. Neurology. 81: 1322-31. PMID 24005336 DOI: 10.1212/Wnl.0B013E3182A8237E  0.314
2013 Murray ME, Bieniek KF, Banks Greenberg M, DeJesus-Hernandez M, Rutherford NJ, van Blitterswijk M, Niemantsverdriet E, Ash PE, Gendron TF, Kouri N, Baker M, Goodman IJ, Petrucelli L, Rademakers R, Dickson DW. Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72. Acta Neuropathologica. 126: 545-54. PMID 23922030 DOI: 10.1007/S00401-013-1161-2  0.405
2013 Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Josephs KA, Knopman DS, White CL, Caselli R, et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Molecular Neurodegeneration. 8: 19. PMID 23800361 DOI: 10.1186/1750-1326-8-19  0.335
2013 Sundal C, Fujioka S, Van Gerpen JA, Wider C, Nicholson AM, Baker M, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Tselis A, Swerdlow RH, Miller BB, et al. Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism & Related Disorders. 19: 869-77. PMID 23787135 DOI: 10.1016/J.Parkreldis.2013.05.013  0.353
2013 Bigio EH, Weintraub S, Rademakers R, Baker M, Ahmadian SS, Rademaker A, Weitner BB, Mao Q, Lee KH, Mishra M, Ganti RA, Mesulam MM. Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 33: 122-33. PMID 22702520 DOI: 10.1111/J.1440-1789.2012.01332.X  0.4
2012 Sundal C, Van Gerpen JA, Nicholson AM, Wider C, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Borjesson-Hanson A, Tselis A, Swerdlow RH, Miller BB, Fujioka S, ... ... Baker M, et al. MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology. 79: 566-74. PMID 22843259 DOI: 10.1212/Wnl.0B013E318263575A  0.337
2012 McDade E, Boeve BF, Burrus TM, Boot BP, Kantarci K, Fields J, Lowe VJ, Peller P, Knopman D, Baker M, Finch N, Rademakers R, Petersen R. Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin. Neurology. 78: 1245-9. PMID 22491866 DOI: 10.1212/Wnl.0B013E318251594C  0.358
2012 Whitwell JL, Weigand SD, Boeve BF, Senjem ML, Gunter JL, DeJesus-Hernandez M, Rutherford NJ, Baker M, Knopman DS, Wszolek ZK, Parisi JE, Dickson DW, Petersen RC, Rademakers R, Jack CR, et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics. Brain : a Journal of Neurology. 135: 794-806. PMID 22366795 DOI: 10.1093/Brain/Aws001  0.415
2012 Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, ... Baker M, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain : a Journal of Neurology. 135: 765-83. PMID 22366793 DOI: 10.1093/Brain/Aws004  0.392
2012 Hsiung GY, DeJesus-Hernandez M, Feldman HH, Sengdy P, Bouchard-Kerr P, Dwosh E, Butler R, Leung B, Fok A, Rutherford NJ, Baker M, Rademakers R, Mackenzie IR. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain : a Journal of Neurology. 135: 709-22. PMID 22344582 DOI: 10.1093/Brain/Awr354  0.41
2012 Stewart H, Rutherford NJ, Briemberg H, Krieger C, Cashman N, Fabros M, Baker M, Fok A, DeJesus-Hernandez M, Eisen A, Rademakers R, Mackenzie IR. Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathologica. 123: 409-17. PMID 22228244 DOI: 10.1007/S00401-011-0937-5  0.418
2012 Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nature Genetics. 44: 200-5. PMID 22197934 DOI: 10.1038/Ng.1027  0.36
2012 Khan B, Rankin K, Sha S, Takada L, Yokoyama J, Karydas A, Fong J, Rutherford N, Baker M, DeJesus-Hernandez M, Coppola G, Rademakers R, Rosen H, Seeley W, Boxer A, et al. C9ORF72 Mutations in Two Patients with Slowly Progressive bvFTD "Phenocopy" (S54.006) Neurology. 78: S54.006-S54.006. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S54.006  0.375
2012 Savica R, Graff-Radford N, DeJesus-Hernandez M, Knopman D, Adeli A, Boot B, Kuntz K, Petersen R, Rutherford N, Baker M, Rademakers R, Boeve B. Clinical Characteristics of Parkinsonism in Frontotemporal Dementia Syndromes Associated with Mutations in MAPT, PGRN, C9ORF72 (P06.075) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P06.075  0.4
2012 Pedraza O, Boeve B, DeJesus-Hernandez M, Rush B, Lucas J, Fields J, Machulda M, Graff-Radford N, Knopman D, Josephs K, Rutherford N, Baker M, Ferman T, Smith G, Ivnik R, et al. Cognitive Endophenotype Associated with the C9ORF72 GGGGCC Expansion in FTD/ALS (P05.063) Neurology. 78: P05.063-P05.063. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P05.063  0.336
2012 Takada L, Sha S, Rankin K, Yokoyama J, Khan B, Karydas A, Fong J, DeJesus-Hernandez M, Rutherford N, Baker M, Rademakers R, Coppola G, Seeley W, Boxer A, Miller B. Neuropsychiatric Features of C9ORF72 Mutation-Associated bvFTD and FTD-ALS (IN9-2.003) Neurology. 78: IN9-2.003-IN9-2.003. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In9-2.003  0.345
2012 Hsiung G, DeJesus-Hernandez M, Feldman H, Sengdy P, Bouchard-Kerr P, Dwosh E, Leung B, Fok A, Rutherford N, Baker M, Rademakers R, Mackenzie IRA. Clinical Heterogeneity in Familial Frontotemporal Dementia and Amyotrophic Lateral Sclerosis Caused by C9ORF72 Mutation (IN9-1.001) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In9-1.001  0.384
2012 Baker MB, Ghiviriga I, Castellano RK. Molecular multifunctionalization via electronically coupled lactones Chemical Science. 3: 1095-1099. DOI: 10.1039/C2Sc00943A  0.579
2012 Kantarci K, Boeve B, Wszolek Z, Przybelski S, Senjem M, Baker M, Knopman D, Rademakers R, Petersen R, Jack C. Anteromedial temporal lobe DTI and structural MRI changes in presymptomatic and symptomatic MAPT mutation carriers Alzheimers & Dementia. 8: 170. DOI: 10.1016/J.Jalz.2012.05.456  0.32
2012 Wicklund M, Boeve B, Daube J, Dejesus-Hernandez M, Parisi J, Dickson D, Josephs K, Baker M, Kuntz K, Johnson K, Knopman D, Ivnik R, Petersen R, Rademachers R. A kindred with familial frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 Alzheimers & Dementia. 8: 169. DOI: 10.1016/J.Jalz.2012.05.451  0.335
2012 Kantarci K, Boeve B, Wszolek Z, Przybelski S, Senjem M, Baker M, Knopman D, Rademakers R, Petersen R, Jack C. Anteromedial temporal lobe diffusion tensor imaging and structural MRI changes in presymptomatic and symptomatic microtubule-associated protein tau (MAPT) mutation carriers Alzheimers & Dementia. 8: 71. DOI: 10.1016/J.Jalz.2012.05.168  0.32
2011 Murray ME, DeJesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR, Wszolek ZK, Ferman TJ, Josephs KA, Boylan KB, Rademakers R, Dickson DW. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathologica. 122: 673-90. PMID 22083254 DOI: 10.1007/S00401-011-0907-Y  0.365
2011 DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 72: 245-56. PMID 21944778 DOI: 10.1016/J.Neuron.2011.09.011  0.347
2011 Kumar N, Boeve BF, Boot BP, Orr CF, Duffy J, Woodruff BK, Nair AK, Ellison J, Kuntz K, Kantarci K, Jack CR, Westmoreland BF, Fields JA, Baker M, Rademakers R, et al. Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein gene. Archives of Neurology. 68: 1165-70. PMID 21911696 DOI: 10.1001/Archneurol.2011.187  0.368
2011 Whitwell JL, Josephs KA, Avula R, Tosakulwong N, Weigand SD, Senjem ML, Vemuri P, Jones DT, Gunter JL, Baker M, Wszolek ZK, Knopman DS, Rademakers R, Petersen RC, Boeve BF, et al. Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD. Neurology. 77: 866-74. PMID 21849646 DOI: 10.1212/Wnl.0B013E31822C61F2  0.301
2011 Whitwell JL, Weigand SD, Gunter JL, Boeve BF, Rademakers R, Baker M, Knopman DS, Wszolek ZK, Petersen RC, Jack CR, Josephs KA. Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRN. Neurology. 77: 393-8. PMID 21753165 DOI: 10.1212/Wnl.0B013E318227047F  0.322
2011 Mackenzie IR, Ansorge O, Strong M, Bilbao J, Zinman L, Ang LC, Baker M, Stewart H, Eisen A, Rademakers R, Neumann M. Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation. Acta Neuropathologica. 122: 87-98. PMID 21604077 DOI: 10.1007/S00401-011-0838-7  0.412
2011 Finch N, Carrasquillo MM, Baker M, Rutherford NJ, Coppola G, Dejesus-Hernandez M, Crook R, Hunter T, Ghidoni R, Benussi L, Crook J, Finger E, Hantanpaa KJ, Karydas AM, Sengdy P, et al. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology. 76: 467-74. PMID 21178100 DOI: 10.1212/Wnl.0B013E31820A0E3B  0.347
2011 Boxer AL, Mackenzie IR, Boeve BF, Baker M, Seeley WW, Crook R, Feldman H, Hsiung GY, Rutherford N, Laluz V, Whitwell J, Foti D, McDade E, Molano J, Karydas A, et al. Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 196-203. PMID 20562461 DOI: 10.1136/Jnnp.2009.204081  0.367
2011 Narożańska E, Jasińska-Myga B, Sitek EJ, Robowski P, Brockhuis B, Lass P, Dubaniewicz M, Wieczorek D, Baker M, Rademakers R, Wszolek ZK, Sławek J. Frontotemporal dementia and parkinsonism linked to chromosome 17--the first Polish family. European Journal of Neurology. 18: 535-7. PMID 20561037 DOI: 10.1111/J.1468-1331.2010.03107.X  0.372
2010 Carrasquillo MM, Nicholson AM, Finch N, Gibbs JR, Baker M, Rutherford NJ, Hunter TA, DeJesus-Hernandez M, Bisceglio GD, Mackenzie IR, Singleton A, Cookson MR, Crook JE, Dillman A, Hernandez D, et al. Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma. American Journal of Human Genetics. 87: 890-7. PMID 21087763 DOI: 10.1016/J.Ajhg.2010.11.002  0.304
2010 DeJesus-Hernandez M, Kocerha J, Finch N, Crook R, Baker M, Desaro P, Johnston A, Rutherford N, Wojtas A, Kennelly K, Wszolek ZK, Graff-Radford N, Boylan K, Rademakers R. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Human Mutation. 31: E1377-89. PMID 20232451 DOI: 10.1002/Humu.21241  0.39
2010 Kelley BJ, Haidar W, Boeve BF, Baker M, Shiung M, Knopman DS, Rademakers R, Hutton M, Adamson J, Kuntz KM, Dickson DW, Parisi JE, Smith GE, Petersen RC. Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin. Archives of Neurology. 67: 171-7. PMID 20142525 DOI: 10.1001/Archneurol.2010.113  0.421
2010 Fraga-Silva RA, Sorg BS, Wankhede M, Dedeugd C, Jun JY, Baker MB, Li Y, Castellano RK, Katovich MJ, Raizada MK, Ferreira AJ. ACE2 activation promotes antithrombotic activity. Molecular Medicine (Cambridge, Mass.). 16: 210-5. PMID 20111697 DOI: 10.2119/Molmed.2009.00160  0.584
2010 Baker MB, Yuan L, Marth CJ, Li Y, Castellano RK. Rapid access to C3- and Cs-symmetric AAT organogelators via ring opening of a common benzotrifuranone precursor Supramolecular Chemistry. 22: 789-802. DOI: 10.1080/10610278.2010.500733  0.658
2009 Whitwell JL, Jack CR, Boeve BF, Senjem ML, Baker M, Ivnik RJ, Knopman DS, Wszolek ZK, Petersen RC, Rademakers R, Josephs KA. Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations. Neurology. 73: 1058-65. PMID 19786698 DOI: 10.1212/Wnl.0B013E3181B9C8B9  0.372
2009 Li Y, Lampkins AJ, Baker MB, Sumpter BG, Huang J, Abboud KA, Castellano RK. Benzotrifuranone: synthesis, structure, and access to polycyclic heteroaromatics. Organic Letters. 11: 4314-7. PMID 19715287 DOI: 10.1021/Ol901631N  0.594
2009 Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain : a Journal of Neurology. 132: 2922-31. PMID 19674978 DOI: 10.1093/Brain/Awp214  0.394
2009 Neumann M, Roeber S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IR. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathologica. 118: 605-16. PMID 19669651 DOI: 10.1007/S00401-009-0581-5  0.375
2009 Whitwell JL, Jack CR, Boeve BF, Senjem ML, Baker M, Rademakers R, Ivnik RJ, Knopman DS, Wszolek ZK, Petersen RC, Josephs KA. Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology. 72: 813-20. PMID 19255408 DOI: 10.1212/01.Wnl.0000343851.46573.67  0.341
2009 Rollinson S, Rizzu P, Sikkink S, Baker M, Halliwell N, Snowden J, Traynor BJ, Ruano D, Cairns N, Rohrer JD, Mead S, Collinge J, Rossor M, Akay E, Guerreiro R, et al. Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration. Neurobiology of Aging. 30: 656-65. PMID 19217189 DOI: 10.1016/J.Neurobiolaging.2009.01.009  0.326
2009 Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R, Bisceglio G, Rovelet-Lecrux A, Boeve B, Petersen RC, Dickson DW, Younkin SG, Deramecourt V, Crook J, Graff-Radford NR, et al. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain : a Journal of Neurology. 132: 583-91. PMID 19158106 DOI: 10.1093/Brain/Awn352  0.403
2009 Kelley BJ, Haidar W, Boeve BF, Baker M, Graff-Radford NR, Krefft T, Frank AR, Jack CR, Shiung M, Knopman DS, Josephs KA, Parashos SA, Rademakers R, Hutton M, Pickering-Brown S, et al. Prominent phenotypic variability associated with mutations in Progranulin. Neurobiology of Aging. 30: 739-51. PMID 17949857 DOI: 10.1016/J.Neurobiolaging.2007.08.022  0.408
2009 Whitwell JL, Jack CR, Boeve BF, Senjem ML, Rademakers R, Baker M, Ivnik RJ, Knopman DS, Wszolek ZK, Petersen RC, Josephs KA. IC-O1-04: Patterns of brain atrophy in frontotemporal dementia with mutations in MAPT or PGRN Alzheimer's & Dementia. 5: P4-P4. DOI: 10.1016/J.Jalz.2009.05.014  0.305
2008 Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, Xu YF, Stewart H, Kelley BJ, Kuntz K, Crook RJ, Sreedharan J, Vance C, Sorenson E, Lippa C, Bigio EH, et al. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. Plos Genetics. 4: e1000193. PMID 18802454 DOI: 10.1371/Journal.Pgen.1000193  0.396
2008 Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ, Finch N, Rutherford NJ, Crook RJ, Josephs KA, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Caselli RJ, et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Human Molecular Genetics. 17: 3631-42. PMID 18723524 DOI: 10.1093/Hmg/Ddn257  0.323
2008 Coppola G, Karydas A, Rademakers R, Wang Q, Baker M, Hutton M, Miller BL, Geschwind DH. Gene expression study on peripheral blood identifies progranulin mutations. Annals of Neurology. 64: 92-6. PMID 18551524 DOI: 10.1002/Ana.21397  0.35
2008 Josephs KA, Whitwell JL, Knopman DS, Hu WT, Stroh DA, Baker M, Rademakers R, Boeve BF, Parisi JE, Smith GE, Ivnik RJ, Petersen RC, Jack CR, Dickson DW. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology. 70: 1850-7. PMID 18401022 DOI: 10.1212/01.Wnl.0000304041.09418.B1  0.311
2008 Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL, Bigio EH, Caselli R, Baker M, Al-Lozi MT, Morris JC, Pestronk A, Rademakers R, et al. TDP-43 A315T mutation in familial motor neuron disease. Annals of Neurology. 63: 535-8. PMID 18288693 DOI: 10.1002/Ana.21344  0.372
2008 Wider C, Melquist S, Hauf M, Solida A, Cobb SA, Kachergus JM, Gass J, Coon KD, Baker M, Cannon A, Stephan DA, Schorderet DF, Ghika J, Burkhard PR, Kapatos G, et al. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology. 70: 1377-83. PMID 17804835 DOI: 10.1212/01.Wnl.0000275527.35752.C5  0.376
2008 Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CH, Bigio EH, Caselli R, Baker M, Al-Lozi MT, Morris JC, Pestronk A, Rademakers R, et al. P3-287: TDP-43 A315T mutation in familial motor neuron disease Alzheimer's & Dementia. 4: T606-T607. DOI: 10.1016/J.Jalz.2008.05.1855  0.341
2007 Rademakers R, Baker M, Gass J, Adamson J, Huey ED, Momeni P, Spina S, Coppola G, Karydas AM, Stewart H, Johnson N, Hsiung GY, Kelley B, Kuntz K, Steinbart E, et al. Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. The Lancet. Neurology. 6: 857-68. PMID 17826340 DOI: 10.1016/S1474-4422(07)70221-1  0.379
2007 Davion S, Johnson N, Weintraub S, Mesulam MM, Engberg A, Mishra M, Baker M, Adamson J, Hutton M, Rademakers R, Bigio EH. Clinicopathologic correlation in PGRN mutations. Neurology. 69: 1113-21. PMID 17522386 DOI: 10.1212/01.Wnl.0000267701.58488.69  0.383
2007 Whitwell JL, Jack CR, Baker M, Rademakers R, Adamson J, Boeve BF, Knopman DS, Parisi JF, Petersen RC, Dickson DW, Hutton ML, Josephs KA. Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Archives of Neurology. 64: 371-6. PMID 17353379 DOI: 10.1001/Archneur.64.3.371  0.35
2007 Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, Knopman DS, Petersen RC, Davies P, Duara R, Graff-Radford NR, Uitti RJ, Rademakers R, Adamson J, Baker M, Hutton ML, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. Journal of Neuropathology and Experimental Neurology. 66: 142-51. PMID 17278999 DOI: 10.1097/Nen.0B013E31803020Cf  0.361
2007 Dächsel JC, Ross OA, Mata IF, Kachergus J, Toft M, Cannon A, Baker M, Adamson J, Hutton M, Dickson DW, Farrer MJ. Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions. Acta Neuropathologica. 113: 601-6. PMID 17151837 DOI: 10.1007/S00401-006-0178-1  0.413
2006 Pickering-Brown SM, Baker M, Gass J, Boeve BF, Loy CT, Brooks WS, Mackenzie IR, Martins RN, Kwok JB, Halliday GM, Kril J, Schofield PR, Mann DM, Hutton M. Mutations in progranulin explain atypical phenotypes with variants in MAPT. Brain : a Journal of Neurology. 129: 3124-6. PMID 17071927 DOI: 10.1093/Brain/Awl289  0.412
2006 Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, Gass J, Cannon A, Rademakers R, Hutton M, Feldman HH. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain : a Journal of Neurology. 129: 3081-90. PMID 17071926 DOI: 10.1093/Brain/Awl271  0.416
2006 Boeve BF, Baker M, Dickson DW, Parisi JE, Giannini C, Josephs KA, Hutton M, Pickering-Brown SM, Rademakers R, Tang-Wai D, Jack CR, Kantarci K, Shiung MM, Golde T, Smith GE, et al. Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study. Brain : a Journal of Neurology. 129: 3103-14. PMID 17030535 DOI: 10.1093/Brain/Awl268  0.416
2006 Huey ED, Grafman J, Wassermann EM, Pietrini P, Tierney MC, Ghetti B, Spina S, Baker M, Hutton M, Elder JW, Berger SL, Heflin KA, Hardy J, Momeni P. Characteristics of frontotemporal dementia patients with a Progranulin mutation. Annals of Neurology. 60: 374-80. PMID 16983677 DOI: 10.1002/Ana.20969  0.394
2006 Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Human Molecular Genetics. 15: 2988-3001. PMID 16950801 DOI: 10.1093/Hmg/Ddl241  0.406
2006 Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 442: 916-9. PMID 16862116 DOI: 10.1038/Nature05016  0.419
2006 Cannon A, Baker M, Boeve B, Josephs K, Knopman D, Petersen R, Parisi J, Dickison D, Adamson J, Snowden J, Neary D, Mann D, Hutton M, Pickering-Brown SM. CHMP2B mutations are not a common cause of frontotemporal lobar degeneration. Neuroscience Letters. 398: 83-4. PMID 16431024 DOI: 10.1016/J.Neulet.2005.12.056  0.398
2006 Mackenzie IR, Baker M, West G, Woulfe J, Qadi N, Gass J, Cannon A, Adamson J, Feldman H, Lindholm C, Melquist S, Pettman R, Sadovnick AD, Dwosh E, Whiteheart SW, et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain : a Journal of Neurology. 129: 853-67. PMID 16401619 DOI: 10.1093/Brain/Awh724  0.372
2005 Rippon GA, Boeve BF, Parisi JE, Dickson DW, Ivnik RI, Jack CR, Hutton M, Baker M, Josephs KA, Knopman DS, Petersen RC. Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer's disease pathology. Neurocase. 11: 204-11. PMID 16006341 DOI: 10.1080/13554790590944753  0.334
2004 Pickering-Brown S, Baker M, Bird T, Trojanowski J, Lee V, Morris H, Rossor M, Janssen JC, Neary D, Craufurd D, Richardson A, Snowden J, Hardy J, Mann D, Hutton M. Evidence of a founder effect in families with frontotemporal dementia that harbor the tau +16 splice mutation. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 125: 79-82. PMID 14755449 DOI: 10.1002/Ajmg.B.20083  0.41
2003 Beach TG, Sue L, Scott S, Layne K, Newell A, Walker D, Baker M, Sahara N, Yen SH, Hutton M, Caselli R, Adler C, Connor D, Sabbagh M. Hippocampal sclerosis dementia with tauopathy. Brain Pathology (Zurich, Switzerland). 13: 263-78. PMID 12946017 DOI: 10.1111/J.1750-3639.2003.Tb00027.X  0.347
2003 Hogg M, Grujic ZM, Baker M, Demirci S, Guillozet AL, Sweet AP, Herzog LL, Weintraub S, Mesulam MM, LaPointe NE, Gamblin TC, Berry RW, Binder LI, de Silva R, Lees A, et al. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy. Acta Neuropathologica. 106: 323-36. PMID 12883828 DOI: 10.1007/S00401-003-0734-X  0.33
2003 Krefft TA, Graff-Radford NR, Dickson DW, Baker M, Castellani RJ. Familial primary progressive aphasia. Alzheimer Disease and Associated Disorders. 17: 106-12. PMID 12794388 DOI: 10.1097/00002093-200304000-00009  0.385
2002 Tsuboi Y, Baker M, Hutton ML, Uitti RJ, Rascol O, Delisle MB, Soulages X, Murrell JR, Ghetti B, Yasuda M, Komure O, Kuno S, Arima K, Sunohara N, Kobayashi T, et al. Clinical and genetic studies of families with the tau N279K mutation (FTDP-17). Neurology. 59: 1791-3. PMID 12473774 DOI: 10.1212/01.Wnl.0000038909.49164.4B  0.384
2002 Walker RH, Friedman J, Wiener J, Hobler R, Gwinn-Hardy K, Adam A, DeWolfe J, Gibbs R, Baker M, Farrer M, Hutton M, Hardy J. A family with a tau P301L mutation presenting with parkinsonism. Parkinsonism & Related Disorders. 9: 121-3. PMID 12473404 DOI: 10.1016/S1353-8020(02)00003-2  0.399
2002 Morris HR, Baker M, Yasojima K, Houlden H, Khan MN, Wood NW, Hardy J, Grossman M, Trojanowski J, Revesz T, Bigio EH, Bergeron C, Janssen JC, McGeer PL, Rossor MN, et al. Analysis of tau haplotypes in Pick's disease. Neurology. 59: 443-5. PMID 12177383 DOI: 10.1212/Wnl.59.3.443  0.331
2002 Tsuboi Y, Uitti RJ, Delisle MB, Ferreira JJ, Brefel-Courbon C, Rascol O, Ghetti B, Murrell JR, Hutton M, Baker M, Wszolek ZK. Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family. Archives of Neurology. 59: 943-50. PMID 12056930 DOI: 10.1001/Archneur.59.6.943  0.366
2002 Tang-Wai D, Lewis P, Boeve B, Hutton M, Golde T, Baker M, Hardy J, Michels V, Ivnik R, Jack C, Petersen R. Familial frontotemporal dementia associated with a novel presenilin-1 mutation. Dementia and Geriatric Cognitive Disorders. 14: 13-21. PMID 12053127 DOI: 10.1159/000058328  0.432
2002 Ponting CP, Hutton M, Nyborg A, Baker M, Jansen K, Golde TE. Identification of a novel family of presenilin homologues. Human Molecular Genetics. 11: 1037-44. PMID 11978763 DOI: 10.1093/Hmg/11.9.1037  0.313
2002 Short RA, Graff-Radford NR, Adamson J, Baker M, Hutton M. Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Archives of Neurology. 59: 611-5. PMID 11939896 DOI: 10.1001/Archneur.59.4.611  0.326
2002 Pickering-Brown SM, Richardson AM, Snowden JS, McDonagh AM, Burns A, Braude W, Baker M, Liu WK, Yen SH, Hardy J, Hutton M, Davies Y, Allsop D, Craufurd D, Neary D, et al. Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain : a Journal of Neurology. 125: 732-51. PMID 11912108 DOI: 10.1093/Brain/Awf069  0.421
2002 Amtul Z, Lewis PA, Piper S, Crook R, Baker M, Findlay K, Singleton A, Hogg M, Younkin L, Younkin SG, Hardy J, Hutton M, Boeve BF, Tang-Wai D, Golde TE. A presenilin 1 mutation associated with familial frontotemporal dementia inhibits gamma-secretase cleavage of APP and notch. Neurobiology of Disease. 9: 269-73. PMID 11895378 DOI: 10.1006/Nbdi.2001.0473  0.37
2001 Russ C, Powell JF, Zhao J, Baker M, Hutton M, Crawford F, Mullan M, Roks G, Cruts M, Lovestone S. The microtubule associated protein Tau gene and Alzheimer's disease--an association study and meta-analysis. Neuroscience Letters. 314: 92-6. PMID 11698154 DOI: 10.1016/S0304-3940(01)02289-3  0.32
2001 Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, St George-Hyslop P, Munoz DG, et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 56: 1702-6. PMID 11425937 DOI: 10.1212/Wnl.56.12.1702  0.336
2001 Bigio EH, Lipton AM, Yen SH, Hutton ML, Baker M, Nacharaju P, White CL, Davies P, Lin W, Dickson DW. Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia. Journal of Neuropathology and Experimental Neurology. 60: 328-41. PMID 11305868 DOI: 10.1093/Jnen/60.4.328  0.371
2001 Russ C, Lovestone S, Baker M, Pickering-Brown SM, Andersen PM, Furlong R, Mann D, Powell JF. The extended haplotype of the microtubule associated protein tau gene is not associated with Pick's disease. Neuroscience Letters. 299: 156-8. PMID 11166961 DOI: 10.1016/S0304-3940(00)01785-7  0.375
2000 Pickering-Brown S, Baker M, Yen SH, Liu WK, Hasegawa M, Cairns N, Lantos PL, Rossor M, Iwatsubo T, Davies Y, Allsop D, Furlong R, Owen F, Hardy J, Mann D, et al. Pick's disease is associated with mutations in the tau gene. Annals of Neurology. 48: 859-67. PMID 11117542 DOI: 10.1002/1531-8249(200012)48:6<859::Aid-Ana6>3.0.Co;2-1  0.409
2000 Houlden H, Baker M, McGowan E, Lewis P, Hutton M, Crook R, Wood NW, Kumar-Singh S, Geddes J, Swash M, Scaravilli F, Holton JL, Lashley T, Tomita T, Hashimoto T, et al. Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Annals of Neurology. 48: 806-8. PMID 11079548 DOI: 10.1002/1531-8249(200011)48:5<806::Aid-Ana18>3.0.Co;2-F  0.386
2000 Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Paul Murphy M, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nature Genetics. 25: 402-5. PMID 10932182 DOI: 10.1038/78078  0.339
2000 Baker M, Graff-Radford D, Wavrant DeVrièze F, Graff-Radford N, Petersen RC, Kokmen E, Boeve B, Myllykangas L, Polvikoski T, Sulkava R, Verkoniemmi A, Tienari P, Haltia M, Hardy J, Hutton M, et al. No association between TAU haplotype and Alzheimer's disease in population or clinic based series or in familial disease. Neuroscience Letters. 285: 147-9. PMID 10793248 DOI: 10.1016/S0304-3940(00)01057-0  0.325
1999 Houlden H, Baker M, Adamson J, Grover A, Waring S, Dickson D, Lynch T, Boeve B, Petersen RC, Pickering-Brown S, Owen F, Neary D, Craufurd D, Snowden J, Mann D, et al. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Annals of Neurology. 46: 243-8. PMID 10443890 DOI: 10.1002/1531-8249(199908)46:2<243::Aid-Ana14>3.0.Co;2-L  0.419
1999 Lincoln S, Crook R, Chartier-Harlin MC, Gwinn-Hardy K, Baker M, Mouroux V, Richard F, Becquet E, Amouyel P, Destée A, Hardy J, Farrer M. No pathogenic mutations in the beta-synuclein gene in Parkinson's disease. Neuroscience Letters. 269: 107-9. PMID 10430516 DOI: 10.1016/S0304-3940(99)00420-6  0.334
1999 Houlden H, Rizzu P, Stevens M, de Knijff P, van Duijn CM, van Swieten JC, Heutink P, Perez-Tur J, Thomas V, Baker M, Morris H, Rossor M, Jannsen JC, Petersen RC, Dodd P, et al. Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations. Neuroscience Letters. 260: 193-5. PMID 10076900 DOI: 10.1016/S0304-3940(98)00931-8  0.382
1999 Lincoln S, Gwinn-Hardy K, Goudreau J, Chartier-Harlin MC, Baker M, Mouroux V, Richard F, Destée A, Becquet E, Amouyel P, Lynch T, Hardy J, Farrer M. No pathogenic mutations in the persyn gene in Parkinson's disease. Neuroscience Letters. 259: 65-6. PMID 10027558 DOI: 10.1016/S0304-3940(98)00901-X  0.335
1998 Isaacs A, Baker M, Wavrant-De Vrièze F, Hutton M. Determination of the gene structure of human GFAP and absence of coding region mutations associated with frontotemporal dementia with parkinsonism linked to chromosome 17. Genomics. 51: 152-4. PMID 9693047 DOI: 10.1006/Geno.1998.5360  0.351
1998 Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393: 702-5. PMID 9641683 DOI: 10.1038/31508  0.407
1998 Crook R, Verkkoniemi A, Perez-Tur J, Mehta N, Baker M, Houlden H, Farrer M, Hutton M, Lincoln S, Hardy J, Gwinn K, Somer M, Paetau A, Kalimo H, Ylikoski R, et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nature Medicine. 4: 452-5. PMID 9546792 DOI: 10.1038/Nm0498-452  0.383
1998 Houlden H, Crook R, Backhovens H, Prihar G, Baker M, Hutton M, Rossor M, Martin JJ, Van Broeckhoven C, Hardy J. ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families. American Journal of Medical Genetics. 81: 117-21. PMID 9514597 DOI: 10.1002/(Sici)1096-8628(19980207)81:1<117::Aid-Ajmg19>3.0.Co;2-M  0.354
1997 Baker M, Kwok JB, Kucera S, Crook R, Farrer M, Houlden H, Isaacs A, Lincoln S, Onstead L, Hardy J, Wittenberg L, Dodd P, Webb S, Hayward N, Tannenberg T, et al. Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21-22. Annals of Neurology. 42: 794-8. PMID 9392579 DOI: 10.1002/Ana.410420516  0.375
1997 Crook R, Ellis R, Shanks M, Thal LJ, Perez-Tur J, Baker M, Hutton M, Haltia T, Hardy J, Galasko D. Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation. Annals of Neurology. 42: 124-8. PMID 9225696 DOI: 10.1002/Ana.410420121  0.384
Low-probability matches (unlikely to be authored by this person)
1998 Hardy J, Pérez-Tur J, Baker M, Farrer M, Crook R, Hutton M, Johnson WG, Gwinn K, Muenter M, Rocca WA, Maraganore D. Exclusion of genetic linkage to 4q21-23 and 17q21 in a family with Lewy body parkinsonism. American Journal of Medical Genetics. 81: 166-71. PMID 9613857 DOI: 10.1002/(Sici)1096-8628(19980328)81:2<166::Aid-Ajmg8>3.0.Co;2-U  0.299
2003 Rippon GA, Crook R, Baker M, Halvorsen E, Chin S, Hutton M, Houlden H, Hardy J, Lynch T. Presenilin 1 mutation in an african american family presenting with atypical Alzheimer dementia. Archives of Neurology. 60: 884-8. PMID 12810495 DOI: 10.1001/Archneur.60.6.884  0.297
1999 Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Human Molecular Genetics. 8: 711-5. PMID 10072441 DOI: 10.1093/Hmg/8.4.711  0.295
2001 Liu WK, Le TV, Adamson J, Baker M, Cookson N, Hardy J, Hutton M, Yen SH, Dickson DW. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Annals of Neurology. 50: 494-502. PMID 11601500 DOI: 10.1002/Ana.1159  0.293
1998 Pennypacker KR, Fuldner R, Xu R, Hernandez H, Dawbarn D, Mehta N, Perez-Tur J, Baker M, Hutton M. Cloning and characterization of the presenilin-2 gene promoter. Brain Research. Molecular Brain Research. 56: 57-65. PMID 9602061 DOI: 10.1016/S0169-328X(98)00028-X  0.293
2014 Jones DT, Weigand S, Przybelski S, Graff-Radford J, Mathew S, Gunter J, Whitwell JL, Knopman DS, Graff-Radford NR, Josephs K, Wszolek Z, Vemuri P, Fields JA, Machulda MM, Ferman TJ, ... ... Baker M, et al. Longitudinal Changes In Brain Mri And Neuropsychological Measures In Asymptomatic And Symptomatic Familial Frontotemporal Lobar Degeneration With Mutations In Mapt Alzheimers & Dementia. 10: 6. DOI: 10.1016/J.Jalz.2014.04.029  0.291
2020 Ghirelli A, Tosakulwong N, Weigand SD, Clark HM, Ali F, Botha H, Duffy JR, Utianski RL, Buciuc M, Murray ME, Labuzan SA, Spychalla AJ, Pham NTT, Schwarz CG, Senjem ML, ... ... Baker M, et al. Sensitivity-specificity of tau and Aβ PET in frontotemporal lobar degeneration. Annals of Neurology. PMID 32869362 DOI: 10.1002/Ana.25893  0.291
2012 Yokoyama J, Takada L, Sha S, Karydas A, Khan B, Fong J, DeJesus-Hernandez M, Rutherford N, Baker M, Rademakers R, Coppola G, Seeley W, Boxer A, Miller B, Rankin K. Differential Effect of the C9ORF72 Hexanucleotide Repeat on Brain Morphology in bvFTD and FTD-ALS (IN9-2.005) Neurology. 78: IN9-2.005-IN9-2.005. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In9-2.005  0.29
2007 Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, et al. Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. American Journal of Human Genetics. 80: 769-78. PMID 17357082 DOI: 10.1086/513320  0.289
2010 Whitwell JL, Jack CR, Parisi JE, Senjem ML, Knopman DS, Boeve BF, Rademakers R, Baker M, Petersen RC, Dickson DW, Josephs KA. Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration? Neurology. 75: 2212-20. PMID 21172844 DOI: 10.1212/Wnl.0B013E31820203C2  0.289
2009 Sitek EJ, Narożańska E, Sławek J, Wieczorek D, Brockhuis B, Lass P, Dubaniewicz M, Jasińska-Myga B, Baker M, Rademakers R, Wszołek ZK. Unilateral neglect in a patient diagnosed with frontotemporal dementia and parkinsonism linked to chromosome 17. Acta Neuropsychiatrica. 21: 209-10. PMID 25384634 DOI: 10.1111/J.1601-5215.2009.00367.X  0.288
2000 Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, Ronald J, Blangero J, Hutton M, Younkin SG. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science (New York, N.Y.). 290: 2303-4. PMID 11125143 DOI: 10.1126/Science.290.5500.2303  0.285
2012 Boeve B, Graff-Radford N, Boylan K, DeJesus-Hernandez M, Knopman D, Josephs K, Pedraza O, Baker M, Dickson D, Petersen R, Rademakers R. O1-05-06: Characterization of frontotemporal dementia +/- amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 Alzheimer's & Dementia. 8: P94-P94. DOI: 10.1016/J.Jalz.2012.05.2129  0.283
2010 Dickson DW, Baker M, Rademakers R. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neuro-Degenerative Diseases. 7: 170-4. PMID 20197700 DOI: 10.1159/000289231  0.283
2009 Jasinska-Myga B, Wider C, Opala G, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Baker M, Rademakers R, Uitti RJ, Farrer MJ, Ross OA, Wszolek ZK. GRN 3'UTR+78 C>T is not associated with risk for Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 16: 909-11. PMID 19473366 DOI: 10.1111/J.1468-1331.2009.02621.X  0.283
2004 Skipper L, Wilkes K, Toft M, Baker M, Lincoln S, Hulihan M, Ross OA, Hutton M, Aasly J, Farrer M. Linkage disequilibrium and association of MAPT H1 in Parkinson disease. American Journal of Human Genetics. 75: 669-77. PMID 15297935 DOI: 10.1086/424492  0.277
2012 Boylan K, DeJesus-Hernandez M, Rush B, Desaro P, Johnston A, Kryston T, Rutherford N, Baker M, Wszolek Z, Dickson D, Rademakers R. Phenotype of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia with ALS (FTD/ALS) Associated with the GGGGCC Repeat Expansion in C9ORF72 (c9FTD/ALS) (IN9-1.004) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In9-1.004  0.277
2005 Rademakers R, Melquist S, Cruts M, Theuns J, Del-Favero J, Poorkaj P, Baker M, Sleegers K, Crook R, De Pooter T, Bel Kacem S, Adamson J, Van den Bossche D, Van den Broeck M, Gass J, et al. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Human Molecular Genetics. 14: 3281-92. PMID 16195395 DOI: 10.1093/Hmg/Ddi361  0.275
2001 Bigio EH, Vono MB, Satumtira S, Adamson J, Sontag E, Hynan LS, White CL, Baker M, Hutton M. Cortical synapse loss in progressive supranuclear palsy. Journal of Neuropathology and Experimental Neurology. 60: 403-10. PMID 11379815 DOI: 10.1093/Jnen/60.5.403  0.275
2011 Kocerha J, Kouri N, Baker M, Finch N, DeJesus-Hernandez M, Gonzalez J, Chidamparam K, Josephs KA, Boeve BF, Graff-Radford NR, Crook J, Dickson DW, Rademakers R. Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations. Bmc Genomics. 12: 527. PMID 22032330 DOI: 10.1186/1471-2164-12-527  0.269
1999 Froelich S, Houlden H, Rizzu P, Chakraverty S, Baker M, Kwon J, Nowotny P, Isaacs A, Nowotny V, Wauters E, van Baren MJ, Oostra BA, Hardy J, Lannfelt L, Goate A, et al. Construction of a detailed physical and transcript map of the FTDP-17 candidate region on chromosome 17q21. Genomics. 60: 129-36. PMID 10486204 DOI: 10.1006/Geno.1999.5892  0.268
2017 Dolzhenko E, van Vugt JJFA, Shaw RJ, Bekritsky MA, van Blitterswijk M, Narzisi G, Ajay SS, Rajan V, Lajoie B, Johnson NH, Kingsbury Z, Humphray SJ, Schellevis RD, Brands WJ, Baker M, et al. Detection of long repeat expansions from PCR-free whole-genome sequence data. Genome Research. PMID 28887402 DOI: 10.1101/Gr.225672.117  0.265
2019 Josephs KA, Murray ME, Tosakulwong N, Weigand SD, Serie AM, Perkerson RB, Matchett BJ, Jack CR, Knopman DS, Petersen RC, Parisi JE, Petrucelli L, Baker M, Rademakers R, Whitwell JL, et al. Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains. Acta Neuropathologica. PMID 30604226 DOI: 10.1007/S00401-018-1951-7  0.261
2009 Derby CA, Rademakers R, Dickson D, Surtees R, Baker M, Katz MJ, Sanders A, Wang C, Lipton RB. P4-132: Progranulin gene polymorphism (GRN rs5848) that is associated with FTLD-U is increased in African-Americans and shows a tendency to correlate with cognitive performance in subjects enrolled in the Einstein Aging Study Alzheimer's & Dementia. 5: P470-P471. DOI: 10.1016/J.Jalz.2009.04.800  0.257
2018 Ooi HW, Mota C, Ten Cate AT, Calore A, Moroni L, Baker MB. Thiol-ene alginate hydrogels as versatile bioinks for bioprinting. Biomacromolecules. PMID 29939754 DOI: 10.1021/Acs.Biomac.8B00696  0.252
2020 Yao T, Wieringa P, Chen H, Chandrakar A, Samal P, Giselbrecht S, Baker MB, Moroni L. Fabrication of a self-assembled honeycomb nanofibrous scaffold to guide endothelial morphogenesis. Biofabrication. PMID 32498043 DOI: 10.1088/1758-5090/Ab9988  0.249
2018 Hafeez S, Ooi HW, Morgan FLC, Mota C, Dettin M, Van Blitterswijk C, Moroni L, Baker MB. Viscoelastic Oxidized Alginates with Reversible Imine Type Crosslinks: Self-Healing, Injectable, and Bioprintable Hydrogels. Gels (Basel, Switzerland). 4. PMID 30674861 DOI: 10.3390/Gels4040085  0.248
2015 Kouri N, Ross OA, Dombroski B, Younkin CS, Serie DJ, Soto-Ortolaza A, Baker M, Finch NC, Yoon H, Kim J, Fujioka S, McLean CA, Ghetti B, Spina S, Cantwell LB, et al. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy. Nature Communications. 6: 7247. PMID 26077951 DOI: 10.1038/Ncomms8247  0.246
2006 Melquist S, Huentelman MJ, Craig DW, Baker M, Crook R, Pearson JV, Zisman VL, Gass J, Adamson J, Szelinger S, Cournevaux JJ, Cannon A, Coon KD, Dickson DW, Stephan D, et al. P3-163: Identification of a novel risk gene for progressive supranuclear palsy by a genome-wide scan of 500,288 SNPs Alzheimer's & Dementia. 2: S422-S422. DOI: 10.1016/J.Jalz.2006.05.1431  0.246
2018 Berrocal JA, Baker MB, Baldini L, Casnati A, Di Stefano S. Inherently chiral cone-calix[4]arenes via a subsequent upper rim ring-closing/opening methodology. Organic & Biomolecular Chemistry. PMID 30259046 DOI: 10.1039/C8Ob01813H  0.244
2020 Yao T, Baker MB, Moroni L. Strategies to Improve Nanofibrous Scaffolds for Vascular Tissue Engineering. Nanomaterials (Basel, Switzerland). 10. PMID 32380699 DOI: 10.3390/Nano10050887  0.243
2016 Garzoni M, Baker MB, Leenders CM, Voets IK, Albertazzi L, Palmans AR, Meijer EW, Pavan GM. Effect of H-Bonding on Order Amplification in the Growth of a Supramolecular Polymer in Water. Journal of the American Chemical Society. PMID 27696835 DOI: 10.1021/Jacs.6B07530  0.242
2017 Ooi HW, Hafeez S, Blitterswijk CAv, Moroni L, Baker MB. Hydrogels that listen to cells: a review of cell-responsive strategies in biomaterial design for tissue regeneration Materials Horizons. 4: 1020-1040. DOI: 10.1039/C7Mh00373K  0.239
2016 Malheiro A, Wieringa P, Mota C, Baker M, Moroni L. Patterning Vasculature: The Role of Biofabrication to Achieve an Integrated Multicellular Ecosystem Acs Biomaterials Science & Engineering. 2: 1694-1709. PMID 33440469 DOI: 10.1021/Acsbiomaterials.6B00269  0.239
2020 Ooi HW, Kocken J, Morgan F, Malheiro ABFB, Zoetebier B, Karperien M, Wieringa PA, Dijkstra P, Moroni L, Baker MB. Multivalency enables dynamic supramolecular host-guest hydrogel formation. Biomacromolecules. PMID 32243138 DOI: 10.1021/Acs.Biomac.0C00148  0.239
2020 Morgan FLC, Moroni L, Baker MB. Dynamic Bioinks to Advance Bioprinting. Advanced Healthcare Materials. e1901798. PMID 32100963 DOI: 10.1002/Adhm.201901798  0.237
2020 Malheiro A, Morgan F, Baker M, Moroni L, Wieringa P. A three-dimensional biomimetic peripheral nerve model for drug testing and disease modelling. Biomaterials. 257: 120230. PMID 32736264 DOI: 10.1016/J.Biomaterials.2020.120230  0.236
2017 Lou X, Lafleur RPM, Leenders CMA, Schoenmakers SMC, Matsumoto NM, Baker MB, van Dongen JLJ, Palmans ARA, Meijer EW. Dynamic diversity of synthetic supramolecular polymers in water as revealed by hydrogen/deuterium exchange. Nature Communications. 8: 15420. PMID 28504253 DOI: 10.1038/Ncomms15420  0.234
2015 Albertazzi L, van der Veeken N, Baker MB, Palmans AR, Meijer EW. Supramolecular copolymers with stimuli-responsive sequence control. Chemical Communications (Cambridge, England). PMID 26390385 DOI: 10.1039/C5Cc06951C  0.233
2020 Baker M, Hong SI, Kang S, Choi DS. Rodent models for psychiatric disorders: problems and promises. Laboratory Animal Research. 36: 9. PMID 32322555 DOI: 10.1186/S42826-020-00039-Z  0.233
2016 Leenders CM, Baker MB, Pijpers IA, Lafleur RP, Albertazzi L, Palmans AR, Meijer EW. Supramolecular polymerisation in water; elucidating the role of hydrophobic and hydrogen-bond interactions. Soft Matter. PMID 26892482 DOI: 10.1039/C5Sm02843D  0.233
2019 Yao T, Chen H, Samal P, Giselbrecht S, Baker MB, Moroni L. Self-assembly of electrospun nanofibers into gradient honeycomb structures Materials & Design. 168: 107614. DOI: 10.1016/J.Matdes.2019.107614  0.232
2014 Leenders CMA, Mes T, Baker MB, Koenigs MME, Besenius P, Palmans ARA, Meijer EW. From supramolecular polymers to hydrogel materials Materials Horizons. 1: 116-120. DOI: 10.1039/C3Mh00103B  0.232
2012 Adeli A, Boeve B, DeJesus-Hernandez M, Baker M, Rutherford N, Knopman D, Ivnik R, Fields J, Petersen R, Rademakers R. Antemortem Characterization of a Kindred Carrying the Non-Coding GGGGCC Hexanucleotide Repeat Expansion in C9ORF72 (IN9-1.009) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In9-1.009  0.231
2015 Meijer B, Baker M, Gosens R, Albertazzi L, Matsumoto N, Palmans A. Exposing Differences in Monomer Exchange Rates of Multi-Component Supramolecular Polymers in Water. Chembiochem : a European Journal of Chemical Biology. PMID 26603687 DOI: 10.1002/Cbic.201500606  0.229
2017 Chen H, Huang X, Zhang M, Damanik F, Baker MB, Leferink A, Yuan H, Truckenmüller R, van Blitterswijk C, Moroni L. Tailoring surface nanoroughness of electrospun scaffolds for skeletal tissue engineering. Acta Biomaterialia. PMID 28690010 DOI: 10.1016/J.Actbio.2017.07.003  0.227
2001 Lewis PA, Piper S, Baker M, Onstead L, Murphy MP, Hardy J, Wang R, McGowan E, Golde TE. Expression of BRI-amyloid beta peptide fusion proteins: a novel method for specific high-level expression of amyloid beta peptides. Biochimica Et Biophysica Acta. 1537: 58-62. PMID 11476963 DOI: 10.1016/S0925-4439(01)00054-0  0.222
2020 Mota C, Camarero-Espinosa S, Baker MB, Wieringa P, Moroni L. Bioprinting: From Tissue and Organ Development to Models. Chemical Reviews. PMID 32407108 DOI: 10.1021/Acs.Chemrev.9B00789  0.221
2015 Neumann LN, Baker MB, Leenders CM, Voets IK, Lafleur RP, Palmans AR, Meijer EW. Supramolecular polymers for organocatalysis in water. Organic & Biomolecular Chemistry. 13: 7711-9. PMID 26083675 DOI: 10.1039/C5Ob00937E  0.221
2005 Pinto LH, Vitaterna MH, Shimomura K, Siepka SM, McDearmon EL, Fenner D, Lumayag SL, Omura C, Andrews AW, Baker M, Invergo BM, Olvera MA, Heffron E, Mullins RF, Sheffield VC, et al. Generation, characterization, and molecular cloning of the Noerg-1 mutation of rhodopsin in the mouse. Visual Neuroscience. 22: 619-29. PMID 16332273 DOI: 10.1017/S0952523805225117  0.22
2019 Yao T, Chen H, Baker MB, Moroni L. Effects of Nanofibers and Coculture with Endothelial Cells on Osteogenesis of Mesenchymal Stem Cells. Tissue Engineering. Part C, Methods. PMID 31774033 DOI: 10.1089/Ten.Tec.2019.0232  0.218
2019 Kuhnt T, Marroquín García R, Camarero-Espinosa S, Dias A, Ten Cate AT, van Blitterswijk CA, Moroni L, Baker MB. Poly(caprolactone-co-trimethylenecarbonate) urethane acrylate resins for digital light processing of bioresorbable tissue engineering implants. Biomaterials Science. PMID 31667486 DOI: 10.1039/C9Bm01042D  0.217
2015 Baker MB, Albertazzi L, Voets IK, Leenders CM, Palmans AR, Pavan GM, Meijer EW. Consequences of chirality on the dynamics of a water-soluble supramolecular polymer. Nature Communications. 6: 6234. PMID 25698667 DOI: 10.1038/Ncomms7234  0.216
2006 Hutton M, Melquist S, Baker M, Zehr C, McGowan E, Dickson D, Eriksen J, Ashe K, Stephan D, Lewis J. S2-02-06: The tauopathies: From genetics to animal models Alzheimer's & Dementia. 2: S26-S26. DOI: 10.1016/J.Jalz.2006.05.086  0.21
2020 Hong SI, Bullert A, Baker M, Choi DS. Astrocytic equilibrative nucleoside transporter type 1 upregulations in the dorsomedial and dorsolateral striatum distinctly coordinate goal-directed and habitual ethanol-seeking behaviors in mice. The European Journal of Neuroscience. PMID 32306482 DOI: 10.1111/Ejn.14752  0.207
2020 Jia YF, Wininger K, Ho AM, Peyton L, Baker M, Choi DS. Astrocytic Glutamate Transporter 1 (GLT1) Deficiency Reduces Anxiety- and Depression-Like Behaviors in Mice. Frontiers in Behavioral Neuroscience. 14: 57. PMID 32390810 DOI: 10.3389/Fnbeh.2020.00057  0.206
2016 Baker MB, Gosens RPJ, Albertazzi L, Matsumoto NM, Palmans ARA, Meijer EW. Cover Picture: Exposing Differences in Monomer Exchange Rates of Multicomponent Supramolecular Polymers in Water (ChemBioChem 3/2016) Chembiochem. 17: 191-191. DOI: 10.1002/Cbic.201600044  0.202
2010 Sitek EJ, Narozańska E, Sławek J, Wójcik J, Wieczorek D, Robowski P, Schinwelski M, Jasińska-Myga B, Baker M, Rademakers R, Wszołek ZK. Psychometric evaluation of personality in a patient with FTDP-17. Psychiatry and Clinical Neurosciences. 64: 211-2. PMID 20447016 DOI: 10.1111/J.1440-1819.2009.02056.X  0.2
2013 Boeve B, Lowe V, Kantarci K, Przybelski S, Weigand S, Spychalla A, Vemuri P, Jones D, McDade E, Kumar N, Rademakers R, Baker M, Knopman D, Petersen R, Parisi J, et al. FDG-PET and PiB-PET imaging in asymptomatic at-risk carriers of a novel octapeptide repeat insertion in PRNP Alzheimers & Dementia. 9: 52. DOI: 10.1016/J.Jalz.2013.05.086  0.198
2020 Kang S, Hong SI, Lee J, Peyton L, Baker M, Choi S, Kim H, Chang SY, Choi DS. Activation of Astrocytes in the Dorsomedial Striatum Facilitates Transition From Habitual to Goal-Directed Reward-Seeking Behavior. Biological Psychiatry. PMID 32564901 DOI: 10.1016/J.Biopsych.2020.04.023  0.196
2017 Lou X, Li B, de Waal BFM, Schill J, Baker MB, Bovee RAA, van Dongen JLJ, Milroy LG, Meijer EW. Fragmentation of organic ions bearing fixed multiple charges observed in MALDI MS. Journal of Mass Spectrometry : Jms. PMID 28963745 DOI: 10.1002/Jms.4035  0.194
2019 Matson JB, Baker MB. Polymers for biology, medicine and sustainability Polymer International. 68: 1219-1219. DOI: 10.1002/Pi.5829  0.193
2018 Chen H, Huang X, Zhang M, Damanik F, Baker MB, Leferink A, Yuan H, Truckenmüller R, van Blitterswijk C, Moroni L. Corrigendum to "Tailoring surface nanoroughness of electrospun scaffolds for skeletal tissue engineering" Acta Biomater. 59 (2017) 82-93. Acta Biomaterialia. PMID 29426725 DOI: 10.1016/J.Actbio.2018.01.030  0.193
2021 Hokelekli FO, Whitwell JL, Machulda MM, Jones DT, Uitti RJ, Pham NTT, Giannini C, Baker M, Lowe VJ, Dickson DW, Josephs KA. Underlying pathology identified after 20 years of disease course in two cases of slowly progressive frontotemporal dementia syndromes. Neurocase. 1-11. PMID 33904372 DOI: 10.1080/13554794.2021.1918723  0.191
2023 Oatman SR, Reddy JS, Quicksall Z, Carrasquillo MM, Wang X, Liu CC, Yamazaki Y, Nguyen TT, Malphrus K, Heckman M, Biswas K, Nho K, Baker M, Martens YA, Zhao N, et al. Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer's disease related proteins. Molecular Neurodegeneration. 18: 2. PMID 36609403 DOI: 10.1186/s13024-022-00592-2  0.178
2014 Taher N, McKenzie C, Garrett R, Baker M, Fox N, Isaacs GD. Amyloid-β alters the DNA methylation status of cell-fate genes in an Alzheimer's disease model. Journal of Alzheimer's Disease : Jad. 38: 831-44. PMID 24077436 DOI: 10.3233/JAD-131061  0.172
2004 Pinto LH, Vitaterna MH, Siepka SM, Shimomura K, Lumayag S, Baker M, Fenner D, Mullins RF, Sheffield VC, Stone EM, Heffron E, Takahashi JS. Results from screening over 9000 mutation-bearing mice for defects in the electroretinogram and appearance of the fundus. Vision Research. 44: 3335-45. PMID 15536001 DOI: 10.1016/J.Visres.2004.07.025  0.158
2021 Josephs KA, Duffy JR, Clark HM, Utianski RL, Strand EA, Machulda MM, Botha H, Martin PR, Pham NTT, Stierwalt J, Ali F, Buciuc M, Baker M, Fernandez De Castro CH, Spychalla AJ, et al. A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech. Nature Communications. 12: 3452. PMID 34103532 DOI: 10.1038/s41467-021-23687-8  0.154
2021 Lepedda AJ, Nieddu G, Formato M, Baker MB, Fernández-Pérez J, Moroni L. Glycosaminoglycans: From Vascular Physiology to Tissue Engineering Applications. Frontiers in Chemistry. 9: 680836. PMID 34084767 DOI: 10.3389/fchem.2021.680836  0.123
2022 Hafeez S, Ooi HW, Suylen D, Duimel H, Hackeng TM, van Blitterswijk C, Baker MB. Desymmetrization via Activated Esters Enables Rapid Synthesis of Multifunctional Benzene-1,3,5-tricarboxamides and Creation of Supramolecular Hydrogelators. Journal of the American Chemical Society. PMID 35196454 DOI: 10.1021/jacs.1c12685  0.112
2022 Hafeez S, Passanha FR, Feliciano AJ, Ruiter FAA, Malheiro A, Lafleur RPM, Matsumoto NM, van Blitterswijk C, Moroni L, Wieringa P, LaPointe VLS, Baker MB. Modular mixing of benzene-1,3,5-tricarboxamide supramolecular hydrogelators allows tunable biomimetic hydrogels for control of cell aggregation in 3D. Biomaterials Science. PMID 35861034 DOI: 10.1039/d2bm00312k  0.108
2011 Baker M, Carr F. Pre-clinical considerations in the assessment of immunogenicity for protein therapeutics. Current Drug Safety. 5: 308-13. PMID 20615174 DOI: 10.2174/157488610792246000  0.104
2022 Agarwal K, Choudhury S, Tipirneni S, Mukherjee P, Ham C, Tamang S, Baker M, Tang S, Kocaman V, Gevaert O, Rallo R, Reddy CK. Preparing for the next pandemic via transfer learning from existing diseases with hierarchical multi-modal BERT: a study on COVID-19 outcome prediction. Scientific Reports. 12: 10748. PMID 35750878 DOI: 10.1038/s41598-022-13072-w  0.104
2023 Feliciano AJ, Grant R, Fernández-Pérez J, Giselbrecht S, Baker MB. Introducing Dynamicity: Engineering Stress Relaxation Into Hydrogels Via Thiol-Ene Modified Alginate for Mechanobiological in vitro Modeling of the Cornea. Macromolecular Bioscience. e2300109. PMID 37401723 DOI: 10.1002/mabi.202300109  0.103
2022 Beeren IAO, Dijkstra PJ, Lourenço AFH, Sinha R, Gomes DB, Liu H, Bouvy N, Baker MB, Camarero Espinosa S, Moroni L. Installation of click-type functional groups enable the creation of an additive manufactured construct for the osteochondral interface. Biofabrication. PMID 36395500 DOI: 10.1088/1758-5090/aca3d4  0.102
2024 Ebrahimi M, Arreguín-Campos M, Dookhith AZ, Aldana AA, Lynd NA, Sanoja GE, Baker MB, Pitet LM. Tailoring Network Topology in Mechanically Robust Hydrogels for 3D Printing and Injection. Acs Applied Materials & Interfaces. PMID 38712527 DOI: 10.1021/acsami.4c03209  0.102
2023 Hafeez S, Aldana A, Duimel H, Ruiter FAA, Decarli MC, Lapointe V, van Blitterswijk C, Moroni L, Baker MB. Molecular tuning of a benzene-1,3,5-tricarboxamide supramolecular fibrous hydrogel enables control over viscoelasticity and creates tunable ECM-mimetic hydrogels and bioinks. Advanced Materials (Deerfield Beach, Fla.). e2207053. PMID 36858040 DOI: 10.1002/adma.202207053  0.101
2023 Hafeez S, Decarli MC, Aldana A, Ebrahimi M, Ruiter FAA, Duimel H, van Blitterswijk C, Pitet LM, Moroni L, Baker MB. In Situ Covalent Reinforcement of a Benzene-1,3,5-Tricarboxamide Supramolecular Polymer Enables Biomimetic, Tough, and Fibrous Hydrogels and Bioinks. Advanced Materials (Deerfield Beach, Fla.). e2301242. PMID 37370137 DOI: 10.1002/adma.202301242  0.101
2021 Morgan FLC, Fernández-Pérez J, Moroni L, Baker MB. Tuning Hydrogels by Mixing Dynamic Cross-Linkers: Enabling Cell-Instructive Hydrogels and Advanced Bioinks. Advanced Healthcare Materials. e2101576. PMID 34614297 DOI: 10.1002/adhm.202101576  0.098
2023 Wang R, Damanik F, Kuhnt T, Jaminon A, Hafeez S, Liu H, Ippel H, Dijkstra PJ, Bouvy N, Schurgers L, Ten Cate AT, Dias A, Moroni L, Baker MB. Biodegradable Poly(ester) Urethane Acrylate Resins for Digital Light Processing: From Polymer Synthesis to 3D Printed Tissue Engineering Constructs. Advanced Healthcare Materials. e2202648. PMID 36864621 DOI: 10.1002/adhm.202202648  0.096
2021 Setayeshmehr M, Hafeez S, van Blitterswijk C, Moroni L, Mota C, Baker MB. Bioprinting Via a Dual-Gel Bioink Based on Poly(Vinyl Alcohol) and Solubilized Extracellular Matrix towards Cartilage Engineering. International Journal of Molecular Sciences. 22. PMID 33918892 DOI: 10.3390/ijms22083901  0.096
2023 Fernández-Pérez J, van Kampen KA, Mota C, Baker M, Moroni L. Flexible, Suturable, and Leak-free Scaffolds for Vascular Tissue Engineering Using Melt Spinning. Acs Biomaterials Science & Engineering. PMID 37490420 DOI: 10.1021/acsbiomaterials.3c00535  0.094
2022 Yao T, van Nunen T, Rivero R, Powell C, Carrazzone R, Kessels L, Wieringa PA, Hafeez S, Wolfs TGAM, Moroni L, Matson JB, Baker MB. Electrospun Scaffolds Functionalized with a Hydrogen Sulfide Donor Stimulate Angiogenesis. Acs Applied Materials & Interfaces. PMID 35715217 DOI: 10.1021/acsami.2c06686  0.091
2021 Aldana AA, Houben S, Moroni L, Baker MB, Pitet LM. Trends in Double Networks as Bioprintable and Injectable Hydrogel Scaffolds for Tissue Regeneration. Acs Biomaterials Science & Engineering. PMID 33606938 DOI: 10.1021/acsbiomaterials.0c01749  0.089
2022 Ruiter FAA, Morgan FLC, Roumans N, Schumacher A, Slaats GG, Moroni L, LaPointe VLS, Baker MB. Soft, Dynamic Hydrogel Confinement Improves Kidney Organoid Lumen Morphology and Reduces Epithelial-Mesenchymal Transition in Culture. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2200543. PMID 35567354 DOI: 10.1002/advs.202200543  0.089
2016 Suter R, Mei Y, Baker M, Benkő Z, Li Z, Grützmacher H. 2,4,6-Tri(hydroxy)-1,3,5-triphosphinine, P3 C3 (OH)3 : The Phosphorus Analogue of Cyanuric Acid. Angewandte Chemie (International Ed. in English). PMID 28026077 DOI: 10.1002/anie.201610156  0.088
2022 Baker MB, Bosman T, Cox MAJ, Dankers P, Dias A, Jonkheijm P, Kieltyka R. Supramolecular Biomaterials in the Netherlands. Tissue Engineering. Part A. PMID 35316128 DOI: 10.1089/ten.TEA.2022.0010  0.086
2021 Shang P, Baker M, Banks S, Hong SI, Choi DS. Emerging Nondopaminergic Medications for Parkinson's Disease: Focusing on A2A Receptor Antagonists and GLP1 Receptor Agonists. Journal of Movement Disorders. PMID 34399565 DOI: 10.14802/jmd.21035  0.085
2021 Geuens T, Ruiter FAA, Schumacher A, Morgan FLC, Rademakers T, Wiersma LE, van den Berg CW, Rabelink TJ, Baker MB, LaPointe VLS. Thiol-ene cross-linked alginate hydrogel encapsulation modulates the extracellular matrix of kidney organoids by reducing abnormal type 1a1 collagen deposition. Biomaterials. 275: 120976. PMID 34198162 DOI: 10.1016/j.biomaterials.2021.120976  0.084
2023 Decarli MC, Seijas-Gamardo A, Morgan F, Wieringa P, Baker MB, Silva JVL, Moraes ÂM, Moroni L, Mota C. Bioprinting of stem cell spheroids followed by post-printing chondrogenic differentiation for cartilage tissue engineering. Advanced Healthcare Materials. e2203021. PMID 37057819 DOI: 10.1002/adhm.202203021  0.083
2023 Zengin A, Teixeira FC, Feliciano T, Habibovic P, Mota CD, Baker MB, van Rijt S. Matrix metalloproteinase degradable, in situ photocrosslinked nanocomposite bioinks for bioprinting applications. Biomaterials Advances. 154: 213647. PMID 37839298 DOI: 10.1016/j.bioadv.2023.213647  0.081
2022 Alessy SA, Alhajji M, Rawlinson J, Baker M, Davies EA. Factors influencing cancer patients' experiences of care in the USA, United Kingdom, and Canada: A systematic review. Eclinicalmedicine. 47: 101405. PMID 35497061 DOI: 10.1016/j.eclinm.2022.101405  0.079
2010 Baker M, Prasad BV. Rotavirus cell entry. Current Topics in Microbiology and Immunology. 343: 121-48. PMID 20397068 DOI: 10.1007/82_2010_34  0.078
2010 Anderson D, Baker M, Grignol G, Hu W, Merchenthaler I, Dudas B. Distribution and morphology of the juxtapositions between growth hormone-releasing hormone-(ghrh)-immunoreactive neuronal elements. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 20: 356-9. PMID 20673733 DOI: 10.1016/j.ghir.2010.06.002  0.078
2015 Baker M, Bastin MT, Cook AM, Fraser J, Hessel E. Hypoxemia associated with nimodipine in a patient with an aneurysmal subarachnoid hemorrhage. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 72: 39-43. PMID 25511836 DOI: 10.2146/ajhp140196  0.077
2021 Passanha FR, Gomes DB, Piotrowska J, Moroni L, Baker MB, LaPointe VLS. A comparative study of mesenchymal stem cells cultured as cell-only aggregates and in encapsulated hydrogels. Journal of Tissue Engineering and Regenerative Medicine. PMID 34655456 DOI: 10.1002/term.3257  0.075
2023 Baker M, Kang S, Hong SI, Song M, Yang MA, Peyton L, Essa H, Lee SW, Choi DS. External globus pallidus input to the dorsal striatum regulates habitual seeking behavior in male mice. Nature Communications. 14: 4085. PMID 37438336 DOI: 10.1038/s41467-023-39545-8  0.075
2021 Hong SI, Kang S, Baker M, Choi DS. Astrocyte-neuron interaction in the dorsal striatum-pallidal circuits and alcohol-seeking behaviors. Neuropharmacology. 108759. PMID 34433087 DOI: 10.1016/j.neuropharm.2021.108759  0.075
2022 Li J, Jamieson WD, Dimitriou P, Xu W, Rohde P, Martinac B, Baker M, Drinkwater BW, Castell OK, Barrow DA. Building programmable multicompartment artificial cells incorporating remotely activated protein channels using microfluidics and acoustic levitation. Nature Communications. 13: 4125. PMID 35840619 DOI: 10.1038/s41467-022-31898-w  0.075
2021 Feliciano AJ, van Blitterswijk C, Moroni L, Baker MB. Realizing Tissue Integration with Supramolecular Hydrogels. Acta Biomaterialia. PMID 33508507 DOI: 10.1016/j.actbio.2021.01.034  0.072
2020 Bezerra MO, Baker M, Palmer MA, Filoso S. Gully formation in headwater catchments under sugarcane agriculture in Brazil. Journal of Environmental Management. 270: 110271. PMID 32721277 DOI: 10.1016/J.Jenvman.2020.110271  0.072
2024 Camarero-Espinosa S, Beeren I, Liu H, Gomes DB, Zonderland J, Lourenço AFH, van Beurden D, Peters M, Koper D, Emans P, Kessler P, Rademakers T, Baker MB, Bouvy N, Moroni L. 3D Niche-Inspired Scaffolds as A Stem Cell Delivery System for The Regeneration of The Osteochondral Interface. Advanced Materials (Deerfield Beach, Fla.). e2310258. PMID 38226666 DOI: 10.1002/adma.202310258  0.07
2020 Ingleby FC, Belot A, Atherton I, Baker M, Elliss-Brookes L, Woods LM. Assessment of the concordance between individual-level and area-level measures of socio-economic deprivation in a cancer patient cohort in England and Wales. Bmj Open. 10: e041714. PMID 33243814 DOI: 10.1136/bmjopen-2020-041714  0.069
2017 Slootweg C, Krachko T, Bispinghoff M, Tondreau A, Stein D, Baker M, Ehlers A, Grützmacher H. Facile Phenylphosphinidene Transfer Reactions from Carbene-Phosphinidene Zinc Complexes. Angewandte Chemie (International Ed. in English). PMID 28505382 DOI: 10.1002/Anie.201703672  0.068
2022 Theakstone A, Brennan PM, Ashton K, Czeiter E, Jenkinson M, Syed K, Reed M, Baker M. Vibrational spectroscopy for the triage of traumatic brain injury CT priority and hospital admissions. Journal of Neurotrauma. PMID 35236121 DOI: 10.1089/neu.2021.0410  0.068
2023 Rogers DM, Agarwal R, Vermaas JV, Smith MD, Rajeshwar RT, Cooper C, Sedova A, Boehm S, Baker M, Glaser J, Smith JC. SARS-CoV2 billion-compound docking. Scientific Data. 10: 173. PMID 36977690 DOI: 10.1038/s41597-023-01984-9  0.068
2022 Yao T, Chen H, Wang R, Rivero R, Wang F, Kessels L, Agten SM, Hackeng TM, Wolfs TGAM, Fan D, Baker MB, Moroni L. Thiol-ene conjugation of VEGF peptide to electrospun scaffolds as potential application for angiogenesis. Bioactive Materials. 20: 306-317. PMID 35755423 DOI: 10.1016/j.bioactmat.2022.05.029  0.067
2020 Shang P, Zhu M, Baker M, Feng J, Zhou C, Zhang HL. Mechanical ventilation in Guillain-Barré syndrome. Expert Review of Clinical Immunology. PMID 33112177 DOI: 10.1080/1744666X.2021.1840355  0.066
2020 Kaplan J, Miller T, Baker M, Due B, Zhao E. A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse. Frontiers in Neurology. 11: 598496. PMID 33414758 DOI: 10.3389/fneur.2020.598496  0.066
2021 Baker M, Blackman S, Cooper E, Smartt K, Walser D, Boland M, Kolar P, Beck AE, Chinn MS. Exploratory analysis of LB 2340 growth in varied concentrations of anaerobically digested pig effluent (ADPE). Heliyon. 7: e08065. PMID 34622069 DOI: 10.1016/j.heliyon.2021.e08065  0.066
2023 Ruiter FAA, King J, Swapnasrita S, Giselbrecht S, Truckenmüller R, LaPointe VLS, Baker MB, Carlier A. Optimization of Media Change Intervals through Hydrogels Using Mathematical Models. Biomacromolecules. PMID 36724373 DOI: 10.1021/acs.biomac.2c00961  0.066
2020 Baker M, Chaichian Y, Genovese M, Derebail V, Rao P, Chatham W, Bubb M, Lim S, Hajian H, Gurtovaya O, Patel U, Tumlin J. Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy. Rmd Open. 6. PMID 33380521 DOI: 10.1136/rmdopen-2020-001490  0.066
2015 Lallement M, Macchi PJ, Vigliano P, Juarez S, Rechencq M, Baker M, Bouwes N, Crowl T. Rising from the ashes: Changes in salmonid fish assemblages after 30months of the Puyehue-Cordon Caulle volcanic eruption. The Science of the Total Environment. 541: 1041-1051. PMID 26473706 DOI: 10.1016/j.scitotenv.2015.09.156  0.064
2021 Smelter DF, Trisler MJ, McCreary EK, Baker M, Copeland K, Dilworth TJ, Rose WE. Long-Acting Lipoglycopeptides Can Interfere With Vancomycin Therapeutic Drug Monitoring. Journal of Clinical Pharmacology. PMID 34564865 DOI: 10.1002/jcph.1975  0.063
2010 Chester KA, Baker M, Mayer A. Overcoming the immunologic response to foreign enzymes in cancer therapy. Expert Review of Clinical Immunology. 1: 549-59. PMID 20477597 DOI: 10.1586/1744666X.1.4.549  0.063
2019 Rutherford D, Baker M. Lateral to medial hamstring activation ratio: Individuals with medial compartment knee osteoarthritis compared to asymptomatic controls during gait. Gait & Posture. 70: 95-97. PMID 30831546 DOI: 10.1016/j.gaitpost.2019.02.026  0.06
2004 Baker MB, Kutka MF, Kelly KJ. Early failure of absorbable plating in a patient with syndromic brachycephaly The Journal of Craniofacial Surgery. 15: 519-522; discussion . PMID 15111821  0.06
2021 Agbontaen KO, Somasundram K, Baker M. Critical COVID-19 in a 24-week pregnant woman with 32 days of invasive mechanical ventilation before delivery of fetus: a case of successful collaborative multidisciplinary care. Bmj Case Reports. 14. PMID 34497055 DOI: 10.1136/bcr-2021-243516  0.06
2021 Kaplan J, Miller T, Baker M, Due B, Zhao E. Repository corticotropin injection improves quality metrics in an observational study of multiple sclerosis relapse. Neurodegenerative Disease Management. 11: 469-476. PMID 34860120 DOI: 10.2217/nmt-2021-0030  0.06
2006 Jaber A, Baker M. Assessment of the immunogenicity of different interferon beta-1a formulations using ex vivo T-cell assays. Journal of Pharmaceutical and Biomedical Analysis. 43: 1256-61. PMID 17118612 DOI: 10.1016/j.jpba.2006.10.023  0.059
2019 Baker M, Stanish W, Rutherford D. Walking challenges in moderate knee osteoarthritis: A biomechanical and neuromuscular response to medial walkway surface translations. Human Movement Science. 68: 102542. PMID 31710922 DOI: 10.1016/j.humov.2019.102542  0.059
2021 Ingleby FC, Woods LM, Atherton IM, Baker M, Elliss-Brookes L, Belot A. Describing socio-economic variation in life expectancy according to an individual's education, occupation and wage in England and Wales: An analysis of the ONS Longitudinal Study. Ssm - Population Health. 14: 100815. PMID 34027013 DOI: 10.1016/j.ssmph.2021.100815  0.059
2014 Issack PS, Barker J, Baker M, Kotwal SY, Lane JM. Surgical management of metastatic disease of the proximal part of the femur. The Journal of Bone and Joint Surgery. American Volume. 96: 2091-8. PMID 25520344 DOI: 10.2106/Jbjs.N.00083  0.058
2023 Feliciano AJ, Soares E, Bosman AW, van Blitterswijk C, Moroni L, LaPointe VLS, Baker MB. Complementary Supramolecular Functionalization Enhances Antifouling Surfaces: A Ureidopyrimidinone-Functionalized Phosphorylcholine Polymer. Acs Biomaterials Science & Engineering. PMID 37413691 DOI: 10.1021/acsbiomaterials.3c00425  0.058
2022 Swan CM, Baker M, Borowy D, Johnson A, Shcheglovitova M, Sparkman A, Neto FV, Van Appledorn M, Voelker N. Loss of phylogenetic diversity under landscape change. The Science of the Total Environment. 822: 153595. PMID 35114247 DOI: 10.1016/j.scitotenv.2022.153595  0.057
2022 Woods LM, Belot A, Atherton IM, Ellis-Brookes L, Baker M, Ingleby FC. Are deprivation-specific cancer survival patterns similar according to individual-based and area-based measures? A cohort study of patients diagnosed with five malignancies in England and Wales, 2008-2016. Bmj Open. 12: e058411. PMID 35688589 DOI: 10.1136/bmjopen-2021-058411  0.057
2024 Lawson C, Kryshtafovych A, Pintilie G, Burley S, Cerny J, Chen V, Emsley P, Gobbi A, Joachimiak A, Noreng S, Prisant M, Read R, Richardson J, Rohou A, Schneider B, ... ... Baker M, et al. Outcomes of the EMDataResource Cryo-EM Ligand Modeling Challenge. Research Square. PMID 38343795 DOI: 10.21203/rs.3.rs-3864137/v1  0.057
2011 Budy P, Baker M, Dahle SK. Predicting fish growth potential and identifying water quality constraints: a spatially-explicit bioenergetics approach. Environmental Management. 48: 691-709. PMID 21769519 DOI: 10.1007/s00267-011-9717-1  0.057
2022 Ward PA, Baker M, Glarbo S, Hill A, Gandhi A, Sokhi J, Lockie C. Emergency intubation in COVID-19 positive patients: comparison of pandemic surges at a UK center. Acute and Critical Care. 37: 263-265. PMID 35698766 DOI: 10.4266/acc.2021.01655  0.056
2021 Pardeshi NN, Ahmadi M, Sierzputowska I, Fogg M, Baker M, Carpenter JF. Subvisible Particles in Solutions of Remicade in Intravenous Saline Activate Immune System Pathways in In Vitro Human Cell Systems. Journal of Pharmaceutical Sciences. PMID 33864780 DOI: 10.1016/j.xphs.2021.04.005  0.055
2020 Vermaas JV, Sedova A, Baker MB, Boehm S, Rogers DM, Larkin J, Glaser J, Smith MD, Hernandez O, Smith JC. Supercomputing Pipelines Search for Therapeutics Against COVID-19. Computing in Science & Engineering. 23: 7-16. PMID 35939280 DOI: 10.1109/MCSE.2020.3036540  0.055
2022 Ingleby FC, Woods LM, Atherton IM, Baker M, Elliss-Brookes L, Belot A. An investigation of cancer survival inequalities associated with individual-level socio-economic status, area-level deprivation, and contextual effects, in a cancer patient cohort in England and Wales. Bmc Public Health. 22: 90. PMID 35027042 DOI: 10.1186/s12889-022-12525-1  0.055
2016 Kivlahan C, Orlowski JM, Pearce J, Walradt J, Baker M, Kirch DG. Taking Risk: Early Results From Teaching Hospitals' Participation in the Center for Medicare and Medicaid Innovation Bundled Payments for Care Improvement Initiative. Academic Medicine : Journal of the Association of American Medical Colleges. PMID 26886810 DOI: 10.1097/ACM.0000000000001121  0.055
2023 Kang S, Hong SI, Kang S, Song M, Yang MA, Essa H, Baker M, Lee J, Bruce RA, Lee SW, Choi DS. Astrocyte activities in the external globus pallidus regulate action-selection strategies in reward-seeking behaviors. Science Advances. 9: eadh9239. PMID 37327345 DOI: 10.1126/sciadv.adh9239  0.054
2006 Dilts DM, Sandler AB, Baker M, Cheng SK, George SL, Karas KS, McGuire S, Menon GS, Reusch J, Sawyer D, Scoggins M, Wu A, Zhou K, Schilsky RL. Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 4553-7. PMID 17008694 DOI: 10.1200/Jco.2006.06.7819  0.054
2023 Baker M, Berens KA, Giesbrecht CJ, Bruer KC, Evans AD, Price HL, Williams S. "Locked in a Jail Cell in Your Own Home": Child Maltreatment Investigators' Perspectives of COVID-19's Effects on Maltreated Children. Child Maltreatment. 10775595231221798. PMID 38086535 DOI: 10.1177/10775595231221798  0.053
2005 Blondino FE, Baker M. Stability of nebulizer admixtures. International Journal of Pharmaceutical Compounding. 9: 323-6. PMID 23925057  0.052
2022 Ghobadi A, Landmann J, Carter A, Cooper ML, Selli ME, Chang J, Baker M, Miller CA, Ferraro F, Chen DY, Smith AM, LaValle TA, Duncavage EJ, Chou J, Tam V, et al. Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies. Blood Advances. PMID 35858291 DOI: 10.1182/bloodadvances.2022007705  0.051
2021 Lalani T, Lee TK, Laing ED, Ritter A, Cooper E, Lee M, Baker M, Baldino T, Mcadoo T, Phogat S, Samuels E, Nguyen H, Broder CC, Epsi N, Richard SA, et al. SARS-CoV-2 Infections and Serologic Responses Among Military Personnel Deployed on the USNS COMFORT to New York City During the COVID-19 Pandemic. Open Forum Infectious Diseases. 8: ofaa654. PMID 33553482 DOI: 10.1093/ofid/ofaa654  0.051
2013 Brinks V, Weinbuch D, Baker M, Dean Y, Stas P, Kostense S, Rup B, Jiskoot W. Preclinical models used for immunogenicity prediction of therapeutic proteins. Pharmaceutical Research. 30: 1719-28. PMID 23649852 DOI: 10.1007/s11095-013-1062-z  0.051
2016 Mak KS, van Bommel AC, Stowell C, Abrahm JL, Baker M, Baldotto CS, Baldwin DR, Borthwick D, Carbone DP, Chen AB, Fox J, Haswell T, Koczywas M, Kozower BD, Mehran RJ, et al. Defining a standard set of patient-centred outcomes for lung cancer. The European Respiratory Journal. PMID 27390281 DOI: 10.1183/13993003.02049-2015  0.049
2019 Retzky JS, Baker M, Hannan CV, Srikumaran U. Single Assessment Numeric Evaluation scores correlate positively with American Shoulder and Elbow Surgeons scores postoperatively in patients undergoing rotator cuff repair. Journal of Shoulder and Elbow Surgery. PMID 31401127 DOI: 10.1016/j.jse.2019.05.039  0.048
2024 Williams S, Patel K, Baker M, Campbell S, Ranellucci J, Talwar V. Elementary school-aged children's perceptions of academic dishonesty: Definitions and moral evaluations of cheating behaviors in school. Journal of Experimental Child Psychology. 242: 105893. PMID 38479320 DOI: 10.1016/j.jecp.2024.105893  0.047
2012 Kramer DB, Baker M, Ransford B, Molina-Markham A, Stewart Q, Fu K, Reynolds MR. Security and privacy qualities of medical devices: an analysis of FDA postmarket surveillance. Plos One. 7: e40200. PMID 22829874 DOI: 10.1371/Journal.Pone.0040200  0.047
2017 Velikova G, Valderas JM, Potter C, Batchelder L, A’Court C, Baker M, Bostock J, Coulter A, Fitzpatrick R, Forder J, Fox D, Geneen L, Gibbons E, Jenkinson C, Jones K, et al. Proceedings of Patient Reported Outcome Measure’s (PROMs) Conference Oxford 2017: Advances in Patient Reported Outcomes Research: Oxford, UK. 8th June 2017 Health and Quality of Life Outcomes. 15: 185-185. PMID 29035171 DOI: 10.1186/S12955-017-0757-Y  0.047
2022 van Kampen KA, Fernández-Pérez J, Baker M, Mota C, Moroni L. Fabrication of a mimetic vascular graft using melt spinning with tailorable fiber parameters. Biomaterials Advances. 139: 212972. PMID 35882129 DOI: 10.1016/j.bioadv.2022.212972  0.046
2018 Rutherford DJ, Baker M. Knee moment outcomes using inverse dynamics and the cross product function in moderate knee osteoarthritis gait: A comparison study. Journal of Biomechanics. PMID 30049451 DOI: 10.1016/j.jbiomech.2018.07.021  0.046
2023 Heldreth AC, Demissie S, Pandya S, Baker M, Gallagher A, Copty M, Azab B, Moko L, Atanassov K, Gave A, Shimotake L, Glinik G, Gross J, Younan D. Stress-Induced (Not Diabetic) Hyperglycemia is Associated With Mortality in Geriatric Trauma Patients. The Journal of Surgical Research. 289: 247-252. PMID 37150079 DOI: 10.1016/j.jss.2023.02.039  0.046
2021 Alessy SA, Lüchtenborg M, Rawlinson J, Baker M, Davies EA. Being assigned a clinical nurse specialist is associated with better experiences of cancer care: English population-based study using the linked National Cancer Patient Experience Survey and Cancer Registration Dataset. European Journal of Cancer Care. PMID 34309952 DOI: 10.1111/ecc.13490  0.046
2019 Baker M, Quesnele J, Baldisera T, Kenrick-Rochon S, Laurence M, Grenier S. Exploring the role of cervical spine endurance as a predictor of concussion risk and recovery following sports related concussion. Musculoskeletal Science & Practice. PMID 31047873 DOI: 10.1016/j.msksp.2019.04.002  0.045
2014 Baker M, Kumar P, Hummel JP, Gehi AK. Non-Inducibility Or Termination As Endpoints Of Atrial Fibrillation Ablation: What Is The Role? Journal of Atrial Fibrillation. 7: 1125. PMID 27957119 DOI: 10.4022/jafib.1125  0.043
2019 Alessy SA, Davies EA, Rawlinson J, Baker M, Lüchtenborg M. How representative are colorectal, lung, breast and prostate cancer patients responding to the National Cancer Patient Experience Survey (CPES) of the cancer registry population in England? A population-based case control study. Bmj Open. 9: e034344. PMID 31848175 DOI: 10.1136/bmjopen-2019-034344  0.041
2012 Panchompoo J, Aldous L, Baker M, Wallace MI, Compton RG. One-step synthesis of fluorescein modified nano-carbon for Pd(II) detection via fluorescence quenching. The Analyst. 137: 2054-62. PMID 22421892 DOI: 10.1039/C2An16261J  0.04
2022 Alessy SA, Davies E, Rawlinson J, Baker M, Lüchtenborg M. Clinical nurse specialists and survival in patients with cancer: the UK National Cancer Experience Survey. Bmj Supportive & Palliative Care. PMID 35450864 DOI: 10.1136/bmjspcare-2021-003445  0.04
2018 Hummel JP, Kadado AJ, Baker M, Gehi AK, Mounsey JP, Sadaf MI, Enriquez AD, Freeman JV, Akar JG. Atrial Fibrillation Thermographic and Endoscopic Monitoring of Patients. Circulation. Arrhythmia and Electrophysiology. 11: e006814. PMID 30562101 DOI: 10.1161/Circep.118.006814  0.04
2024 Locke DH, Baker M, Alonzo M, Yang Y, Ziter CD, Murphy-Dunning C, O'Neil-Dunne JPM. Variation the in relationship between urban tree canopy and air temperature reduction under a range of daily weather conditions. Heliyon. 10: e25041. PMID 38352758 DOI: 10.1016/j.heliyon.2024.e25041  0.036
2017 Rutherford D, Baker M, Wong I, Stanish W. Dual-belt treadmill familiarization: Implications for knee function in moderate knee osteoarthritis compared to asymptomatic controls. Clinical Biomechanics (Bristol, Avon). 45: 25-31. PMID 28458186 DOI: 10.1016/j.clinbiomech.2017.04.006  0.035
2017 Potter CM, Batchelder L, A'Court C, Geneen L, Kelly L, Fox D, Baker M, Bostock J, Coulter A, Fitzpatrick R, Forder JE, Gibbons E, Jenkinson C, Jones K, Peters M. Long-Term Conditions Questionnaire (LTCQ): initial validation survey among primary care patients and social care recipients in England. Bmj Open. 7: e019235. PMID 29101153 DOI: 10.1136/bmjopen-2017-019235  0.033
2017 Guina J, Baker M, Stinson K, Maust J, Coles J, Broderick P. Should Posttraumatic Stress Be a Disorder or a Specifier? Towards Improved Nosology Within the DSM Categorical Classification System. Current Psychiatry Reports. 19: 66. PMID 28808897 DOI: 10.1007/s11920-017-0821-7  0.032
2006 Gazi E, Baker M, Dwyer J, Lockyer NP, Gardner P, Shanks JH, Reeve RS, Hart CA, Clarke NW, Brown MD. A Correlation of FTIR Spectra Derived from Prostate Cancer Biopsies with Gleason Grade and Tumour Stage European Urology. 50: 750-761. PMID 16632188 DOI: 10.1016/j.eururo.2006.03.031  0.031
2020 Rutherford DJ, Moyer R, Baker M, Saleh S. High day-to-day repeatability of lower extremity muscle activation patterns and joint biomechanics of dual-belt treadmill gait: A reliability study in healthy young adults. Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology. 51: 102401. PMID 32087511 DOI: 10.1016/j.jelekin.2020.102401  0.031
2017 Rutherford D, Baker M, Wong I, Stanish W. The effect of age and knee osteoarthritis on muscle activation patterns and knee joint biomechanics during dual belt treadmill gait. Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology. 34: 58-64. PMID 28411486 DOI: 10.1016/j.jelekin.2017.04.001  0.03
2020 Baker M, Todd S, Shet NS. A Rare Cause of Diffuse Forearm Swelling in an Infant. Pediatrics in Review. 41: 652-654. PMID 33262157 DOI: 10.1542/pir.2019-0154  0.029
2022 Rutherford D, Baker M, Urquhart N, Stanish W. The effect of a frontal plane gait perturbation bout on knee biomechanics and muscle activation in older adults and individuals with knee osteoarthritis. Clinical Biomechanics (Bristol, Avon). 92: 105574. PMID 35066441 DOI: 10.1016/j.clinbiomech.2022.105574  0.029
2018 Alberti PM, Sutton KM, Baker M. Changes in Teaching Hospitals' Community Benefit Spending After Implementation of the Affordable Care Act. Academic Medicine : Journal of the Association of American Medical Colleges. PMID 29794520 DOI: 10.1097/Acm.0000000000002293  0.027
2017 Kumar P, Baker M, Gehi AK. Comparison of Single-Coil and Dual-Coil Implantable Defibrillators: A Meta-Analysis. Jacc. Clinical Electrophysiology. 3: 12-19. PMID 29759689 DOI: 10.1016/j.jacep.2016.06.007  0.024
2010 De Groot AS, Baker M, Cohen T. Species neutral correlates of immunogenicity for vaccines and protein therapeutics: fact or science fiction. Human Vaccines. 6: 371-2. PMID 20551718  0.024
2023 Baker M, Campbell S, Patel K, McWilliams K, Williams S. An examination of questioning methods and the influence of child maltreatment on paediatric pain assessments: Perspectives of healthcare providers. Journal of Evaluation in Clinical Practice. PMID 38062796 DOI: 10.1111/jep.13950  0.023
2008 Baker M. On "Unanticipated death after discharge home from the emergency department". Annals of Emergency Medicine. 51: 215-6; author reply . PMID 18206561 DOI: 10.1016/j.annemergmed.2007.08.031  0.022
2015 Suding K, Higgs E, Palmer M, Callicott JB, Anderson CB, Baker M, Gutrich JJ, Hondula KL, LaFevor MC, Larson BM, Randall A, Ruhl JB, Schwartz KZ. Conservation. Committing to ecological restoration. Science (New York, N.Y.). 348: 638-40. PMID 25953995 DOI: 10.1126/Science.Aaa4216  0.021
2010 Cannon B, Chan L, Rowlinson JS, Baker M, Clancy M. Digital anaesthesia: one injection or two? Emergency Medicine Journal : Emj. 27: 533-6. PMID 20360491 DOI: 10.1136/emj.2009.072850  0.018
2019 Vora D, Baker M, Pandarinath R. Impact of Clavicle Fractures on Return to Play and Performance Ratings in NFL Athletes. Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine. 29: 459-464. PMID 31688175 DOI: 10.1097/JSM.0000000000000548  0.016
2023 Campbell S, Baker M, McWilliams K, Williams S. Child maltreatment and pediatric pain: A survey of healthcare professionals' pain knowledge and pain management techniques. Journal of Child Health Care : For Professionals Working With Children in the Hospital and Community. 13674935231167965. PMID 37018753 DOI: 10.1177/13674935231167965  0.014
2022 Kizzee RL, Baker M, Launier K. Hyperbilirubinemia in an Infant with Delayed Eye Tracking. Pediatrics in Review. 43: 525-528. PMID 36045160 DOI: 10.1542/pir.2021-004956  0.012
2021 Annabi N, Baker M, Boettiger A, Chakraborty D, Chen Y, Corbett KS, Correia B, Dahlman J, de Oliveira T, Ertuerk A, Yanik MF, Henaff E, Huch M, Iliev ID, Jacobs T, et al. Voices of biotech research. Nature Biotechnology. PMID 33692517 DOI: 10.1038/s41587-021-00847-1  0.01
Hide low-probability matches.